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A GENETIC TEST OF THE ROLE OF ACTIVINS IN MOUSE MESODERM
FORMATION
ABSTRACT
Vertebrate embryos acquire their basic body plan through a series of inductions, the first of which
is mesoderm formation. In Xenopus embryo explants, certain polypeptide growth factors are able
to induce many morphological and molecular changes that normally accompany mesoderm
formation. Among the most potent inducers are the activin family of TGFP-like factors. In exposed
explants, cells normally fated to form ectoderm differentiate into mesoderm, as muscle and
notochord, and undergo characteristic morphogenetic movements. Activins are expressed in
many early vertebrate embryos. Conclusive demonstration of activin involvement in gastrulation
however requires ablation of the molecule in the developing animal. Genetic analysis of
development is not possible in Xenopus. In contrast, the technology of targeted mutagenesis in
mice allows to generate animals lacking activins. Activins are :03 hetero or homodimers of PA and
3B subunits, that also heterodimerize with an a subunit to form inhibins. Targeted disruption of
the PB subunit gene leads to generation of mice lacking activins B, AB, and inhibin B.
Surprisingly, they were viable, but exhibited a very specific defect in eyelid morphogenesis, and a
female reproductive dysfunction. Mutant females were able to give birth to morphologically normal
progeny, including homozygous OB mutants. However, many offspring died perinatally, revealing
a yet incompletely defined maternal failure. Elaboration of the mouse body plan thus requires
neither maternal nor embryonic activin OB. Mutant mice were found to upregulate OA expression.
Because of the possible functional overlap between PA and PB, we crossed OB mutant mice with a
3A deficient strain. At birth the activin PA mutant mice exhibit a number of craniofacial
abnormalities, including lack of incisors and whiskers, and palate malformations. Mutants die
postnatally, due to inability to suckle. Upon intercrossing PA/P3B compound heterozygotes,
compound homozygotes displayed at birth both eyelid defect and lack of whiskers, with palate
malformations. The double mutant phenotype was thus no more severe than the sum of the two
single mutant phenotypes. Therefore there is no functional overlap between 3A and 1B during
mouse embryogenesis. The two factors mediate independent, pleiotropic, and highly specific
functions in development. Although the role played by maternal PA and 3B needs further
investigation, we conclude that murine mesoderm and axis formation can occur in the absence of
zygotic activins, in contrast to what had been speculated from amphibian studies.
Anne Vassalli
Thesis Supervisor: Rudolf Jaenisch, Professor, MIT
Whatever happens. Whatever
What is is is what
I want. Only that. But that.
Galway Kinnel
"A la fin, la verite est la seule chose qui vaille d'etre possedee: elle est plus
emouvante que I'amour, plus joyeuse, plus passionnee. Elle ne peut pas vous
trahir. Rien ne tient, qu'elle. Moi, en tout cas, je lui donne ce qui me reste a
vivre et seulement a elle."
Katherine Mansfield Journal 17 dec. 1919
(original english version out of press)
'I'm talking about this town,' F. Jasmine said in a higher voice. 'There are all
these people here I don't even know by sight or name. And we pass alongside
each other and don't have any connexion. And they don't know me and I don't
know them. And now I'm leaving town and there are all these people I will never
know.'
'But who do you want to know ?' asked Berenice.
F. Jasmine answered : ' Everybody . In the world . Everybody in the world. '
Carson Mac Cullers
TABLE OF CONTENTS
PART 1: A GENETIC TEST OF THE ROLE OF ACTIVINS IN MOUSE MESODERM
FORMATION
S U M M A R Y ...................................................................................................... ............... 7
INTRODUCTION: 1.1 Embryonic inductions............................... ............... 9
1.2 Morphogens............................................... 10
1.3 Mesoderm induction....................................................... 12
1.4 The pleiotropism of activins............................. ...... 13
1.5 Structure of activins and their receptors ...................... 14
1.6 Expression of activins in embryos.............................. 14
1.7 Working hypothesis and strategy............................. 15
ACTIVIN / INHIBIN 3B SUBUNIT GENE DISRUPTION LEADS TO DEFECTS IN
EYELID DEVELOPMENT AND FEMALE REPRODUCTION (Vassalli et al., 1994)
Abstract..................................................25
Introduction.........................................26
Results..................................................28
i. Mice homozygous for a targeted mutation in the
activin / inhibin iB subunit gene are viable............................................. 28
ii. Mutant mice lack wild-type mRNA and mature iB
p ep tide........................................................................................................................... 29
iiii. The pB-deficient ovary up-regulates expression
of the PA subunit........................................................................................... ............. 3 0
iv. Failure of eyelid fusion at birth ........................... 30
v. Mutant females manifest a reproductive impairment
vi. Mutant females show increased gestation time and
decreased nursing ability .......................................................................................... 32
vii. FSH measurements in mutant animals ............. 33
Discussion.................................... 47
Methods................................................. 51
i. Cloning of the mouse activin / inhibin iB subunit
gene and construction of targeting vectors ........................................ ..... 51
ii. PCR cloning of mouse PB subunit exon probes..51
3
iii. Transfection and selection of ES cells ................. 52
iv. Screening of recombinant ES clones and animal
g en o typ in g ..................................................................................................................... 5 3
v. Blastocyst injections and breeding of chimeras...53
vi. RNA analysis.............................................................. 53
vii. Protein analysis.......................................... ........... 54
viii. Histological analysis................................... ......... 54
ix. FSH measurements ............................................... 54
Acknowledgments........................... ......... 55
APPENDIX 1 : FUNCTIONAL ANALYSIS OF ACTIVINS IN MAMMALIAN
DEVELOPMENT (Matzuk et al., in press)................................... .......... 56
GENERAL DISCUSSION: 1.8 The phenotype of activin I inhibin B deficiency:
i. V ia b ility ....................................................... ............... 7 2
ii. Failure of eyelid fusion............................... .... 73
iii. Female reproductive dysfunction.......................74
1.9 Limitations of single gene knockouts and strategies to
overcome them:
i. Spatial and temporal analysis of development......76
ii. Analysis of expression of related genes............76
iii. 'Double KOs'.................................... ....... 77
1.10 The importance of maternal effects............................79
1.11 Constitutive KO vs inducible KO.................................80
1.12 The real mesoderm inducer ?...................................... 81
PA RT 1 : R EFER ENC ES............................................ .............................................. 83
APPENDIX 2 : RANDOM INSERTIONAL MUTAGENESIS: THE MOV34
EM B RY O N IC LETHA L............................................... ................................................ 95
Abstract................................................ ........... .............. 96
Introduction........................................... ........... ............. 97
R e s u lts ......................................... ........................................... 9 9
i. Expression of the Mov34 mRNA in oocytes,
preimplantation embryos and adult tissues................................................. ..... 99
ii. Raising of antisera to the predicted Mov34 protein......100
4
iii. Identification of the Mov34 protein in mouse cells......1 01
iv. Localization of the Mov34 protein in mouse cells........101
Discussion............................................ ....................... 111
Methods ................................................ ....................... 114
i. Mouse oocyte and preimplantation embryo collection.. 1 4
ii. RNA extraction from oocytes and preimplantation
em b ry o s ....................................... ............................................................................. 1 14
iii. Raising of antisera.............................................................114
iv. Peptide-carrier coupling............................... ..... 114
v. Immunoaffinity purification of antibodies ....................... 11 5
vi. In vitro translation and immunoprecipitation of the Mov34
g ene p ro duct ............................................................................................................... 116
vii. Cell protein extracts.......................................................116
viii. Western analysis.................................. ............ 117
ix. Immunofluorescence........................................................... 17
x. Immunofluorescence alternate protocol ...................... 1...17
Appendix 2 : References.............................. ........ 118
A C K NO W LEDG EM ENTS ....................................................................................... ...... 121
PART 1:
A GENETIC TEST OF THE ROLE OF ACTIVINS IN MOUSE
MESODERM FORMATION
Part 1
PART 1 : SUMMARY
Vertebrate embryos acquire their basic body plan through a series of inductive events, the first of
which is mesoderm formation. The past seven years have witnessed major advances in this field.
This is in great part due to work in amphibians, and the discovery that certain polypeptide growth
factors were able to induce in embryonic explants many of the same morphological and molecular
changes that, in intact embryos, accompany mesoderm formation. This provided an entry for the
identification of gene products that participate in specification of the body plan. Candidate
effectors were in turn analyzed for their presence and effects in other vertebrates. Many of the
molecules suggested to be involved in these processes were found to be conserved among
vertebrates in their expression pattern, and in some cases their activities. Thus, the consensus
thought has been that early patterning mechanisms were shared among vertebrates. The
amphibian embryo assays, such as the animal cap assay, and RNA microinjections have been
extremely powerful in the identification of novel candidate genes, and have provided functional
assays for the role of specific extracellular signals by the use of dominant-negative receptors.
Conclusive demonstration of the involvement of a molecule in a process requires however
ablation of the molecule in the developing animal. Genetical analysis of development is not
possible in Xenopus laevis. In contrast, the existing technology of targeted mutagenesis in mice
offers the means to test the involvement of any factor whose gene is available.
Among the most potent mesoderm inducers in the amphibian animal cap assay, are the
activin family of TGFP-like factors. In animal cap cells, activins induce immediate-early genes, as
Brachyury and goosecoid and other homeobox and fork-head genes believed to participate in
early morphogenesis. Cells differentiate into mesodermal types, such as muscle and notochord,
rather than following their natural ectodermal fate. At the macroscopic level, animal caps exposed
to activin 'elongate', as they undergo morphogenetic cell movements that resemble the ones that
occur during gastrulation. Therefore activins appear to trigger responses that recapitulate many of
the events of gastrulation. In support of their role in these processes is also the fact that activins
are expressed in early fish, frog, chicken and mouse embryos.
To test the involvement of activins in early development, we have used gene targeting to
generate mice lacking these factors. Activins are 3:p hetero- or homodimers of two subunits, PA
and OB, that also dimerize with an a subunit to form inhibins. Targeted disruption of the PB subunit
gene of activin / inhibin leads to generation of mice lacking activins B, AB, as well as inhibin B.
These mice were found to be viable. They exhibit a very specific defect in eyelid morphogenesis
and a female reproductive dysfunction. Female mutants are able to give birth to morphologically
normal progeny, including homozygous activin B mutants, but the offspring most often die
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perinatally due to a yet incompletely defined maternal failure. This demonstrated that both
maternal and embryonic expression of activin B is dispensable for mesoderm formation in the
mouse, although maternal OB is important for survival of neonates. Because of the possible
functional overlap of the related activin PA with activin PB, we have crossed the OB mutant mice
with a strain of mice in which the exon encoding the activin / inhibin PA mature peptide was
deleted by homologous recombination in ES cells. At birth the activin PA mutant mice exhibit a
whisker-less phenotype and secondary palate malformations interfering with suckling, and they
die postnatally. Upon intercrossing OA / PB compound heterozygotes, we obtained individuals
displaying both eyelid defect and lack of whiskers at birth, with palate malformations. These mice
were not viable, and represented the PA / PB compound homozygous mutant progeny. Thus, the
double mutant phenotype was no more severe than the sum of the two single mutant
phenotypes. This indicates that there is no apparent functional overlap between activins PA and
OB during mouse embryogenesis. These two factors appear to mediate independent, pleiotropic,
and very specific functions at various times of development. Although the role played by maternal
activin A needs further investigation, we conclude from this work that murine mesoderm and axis
formations can occur in the absence of zygotic activins, in contrast to what had been speculated
from the earlier amphibian studies.
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PART 1 : INTRODUCTION:
In this section, I attempt to introduce the concepts of embryonic inductions and of morphogens.
Mesoderm induction has been thought to involve activin peptides. These peptides are the first
vertebrate factors to have been shown to display the remarkable property of evoking dose-
dependent cell fates in responding cells, and thus to behave as the postulated 'morphogens'.
Focusing on this family of growth factors, I am next describing their wide pleiotropism of effects,
their expression, particularly in the embryo, which led to the working hypothesis at the basis of this
thesis.
1.1 Embryonic inductions
The basic body plan of a vertebrate embryo is established through a series of embryonic
inductions. Underlying these events are cell to cell interactions where a cell or a group of cells
send a signal to responding cells to alter their fate. The signal ('inducer') may be freely diffusible,
or may be limited in its diffusion by attachment to the extracellular matrix or to the cell surface: its
direct range of action is thus more or less restricted. In either instance, an inducer may organize
the patterning of an entire morphogenetic field. A short range inducer may initiate a cascade of
local, sequential inductions that will create a variety of cell types arranged in a specific spatial array.
A more diffusible inducer may build a concentration gradient and elicit in an initially homogeneous
population of cells responses that are dose-dependent; it therefore constitutes a 'morphogen' on
its own. Long range inducers with concentration-dependent responses are specifically referred to
as morphogens (Wolpert, 1969).
Tissues that are sources of inducers are called 'organizers' because of their ability, as
assayed by ectopic transplantation, of organizing in the host tissue a new pattern that would not
otherwise have arisen. Organizer regions in the embryo convey positional information to a cell
(Wolpert, 1969) and modify its differentiation. Examples of organizers are:
(a) The "Spemann organizer" was the first organizer to be recognized. Hans Spemann (1938)
observed that the dorsal blastoporal lip of the newt early gastrula had unique properties within the
embryo. Upon transplantation to the ventral side of a host, this region was able to recruit host
tissue, altering its fate and inducing the formation of a full secondary axis, comprising a neural
tube, notochord, paraxial mesoderm and gut. Thus, the organizer controls long range
organization of pattern and is able to specify intrinsic polarities of axes. The inducer molecule(s)
responsible for this effect are still not resolved.
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(b) The notochord (dorsal axial mesoderm) is essential in the induction and/or maintenance, and
patterning of the neural tissue. Various newly discovered extracellular signals, as noggin,
follistatin and hedgehog, have been speculated to be involved in mediating diverse aspects of
neural induction and patterning (Echelard et al., 1993; Krauss et al.,1993; Lamb et al., 1993;
Hemmati-Brivanlou et al., 1994; Roelink et al.,1994).
(c) The Zone of Polarizing Activity (ZPA) mediates limb patterning. A specific group of cells in the
posterior margin of the limb bud specifies the pattern of digit formation across the entire limb
(Tickle et al., 1975). The signalling molecule hedgehog appears to be a very good candidate
mediator of the ZPA (Riddle et al., 1993). Whether hedgehog acts in this process as a morphogen
(establishing a concentration gradient that specifies position to the cell) or by involving
subsequent inducers is not yet known.
1.2 Morphogens
The first gene products to be described as morphogens were not in fact extracellular, secreted
proteins but transcription factors. The bicoid and hunchback gene products control the antero-
posterior (a-p) patterning of the early Drosophila embryo (Nusslein-Volhard et al., 1987), and
nuclear dorsal protein organizes the dorso-ventral (d-v) pattern (Jiang and Levine, 1993, and ref.
therein). Each of these proteins is distributed in a gradient in the early syncytial embryo, and
different concentrations of nuclear protein induce the transcription of different target genes. The
bicoid and hunchback gradients depend on free diffusion of the proteins from localized RNA
sources within the syncytial cytoplasm of the early embryo. In contrast, morphogenetic
transcription factors that act in cellularized embryos have to rely on other mechanisms to generate
a gradient of their distribution. For example, the mRNA for the homeo-domain protein goosecoid
was shown to be distributed in a graded fashion in the marginal zone of Xenopus embryos, and
elicits in cells concentration-dependent responses that recapitulate a d-v axis (Niehrs et al., 1994).
Establishment of the goosecoid mRNA gradient presumably reflects the graded activity of an
unknown extracellular component which itself must be a morphogen.
In contrast to nuclear factors, extracellular proteins with the demonstrated property of a
morphogen as defined above, are only a few and are decribed below. In Drosophila, the
decapentaplegic and hedgehog secreted factors have both been shown by genetic means to
behave as 'true' morphogens, at least in a subset of their pleiotropic activities. In vertebrates,
however, the properties of morphogens have been ascribed only to the activin family of growth
factors:
(a) The decapentaplegic (dpp) gene of the Transforming Growth Factor-1 (TGF3) superfamily is
one of the zygotic genes essential for the specification of the d-v axis within the presumptive
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ectoderm of Drosophila embryos. Genetic and RNA injection experiments have very elegantly
demonstrated that dpp acts as a morphogen. Increasing doses of dpp specify more dorsal cell
types, and different doses of the protein are sufficient to specify at least three distinct cell fates,
ventral neurogenic ectoderm, dorsal epidermis, and extraembryonic amnioserosa. Thus, localized
dpp RNA injections into mutant embryos that lack any inherent d-v polarity show that dpp can both
define embryonic polarity and organize detailed patterning within the ectoderm (Ferguson and
Anderson, 1992).
(b) The hedgehog (hh) gene product, as one of its several activities, specifies the array of
cuticular cell types found across the epidermis of each Drosophila segment (Heemskerk and
DiNardo, 1994). This was demonstrated by expressing in the epidermis increasing amounts of hh
protein through the use of a heat-shock driven hh transgene, and showing that augmenting hh
levels converts cell identity to a type more proximal to the endogenous hh expressing cells.
Therefore, the latter cells act as a source of a long-range patterning signal.
(c) Activins A and B, members, as dpp, of the TGFO superfamily and similarly displaying pleiotropic
activities, behave in Xenopus embryo explants as very potent inducers of dorsal mesoderm, such
as notochord and muscle (see below). When applied to disaggregated animal pole cells, they are
able to elicit cell types of a progressively more antero-dorsal character as peptide concentration
rises. Using a variety of histological and molecular probes (see fig.ii), Green et al. (1992)
distinguished 5 distinct cell fates induced by increasing doses of activin. These were: epidermis,
posterolateral mesoderm, muscle, notochord, and goosecoid-expressing organizer tissue. The
responses to activin displayed a very high sensitivity to peptide dose, discriminating differences in
concentration of a factor of less than 2, and were separated by sharp thresholds. Thus increasing
activin concentration in vitro elicited cell fates found along an entire embryo axial dimension. This
led Green et al. (1992) to postulate that an endogenous gradient of activin within the amphibian
embryo plays an essential role in specifying the elements of the body plan.
Whereas the activity of dpp as a morphogen has been conclusively demonstrated in vivo
in Drosophila, activin dose-dependent responses have still to be evidenced in vivo in Xenopus
whole embryos * . However, it is extremely striking that in both Xenopus and Drosophila, a TGFO
family member evokes a series of dorsal pattern elements with small increases in concentration.
The similarity of dose-response relationships in both species suggests that specification of d-v
pattern by TGFP family members may be operating in distant species, and that the biochemical
mechanisms involved in establishing and interpreting these small differences in TGFO peptide
concentration within the embryo may also be conserved.
* Recently, Gurdon et al. (1994) have demonstrated graded responses of cells to an activin
gradient in embryonic frog tissues.
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1.3 Mesoderm induction
The first induction to take place in the vertebrate embryo leads to mesoderm formation.
Experimental embryologists have studied this process since early in this century. However an
understanding of the underlying mechanisms in molecular terms has only very recently started to
be possible.
The amphibian animal cap assay, pioneered by Peter Nieuwkoop (1969) and later used in
a variety of experimental designs, has been an extraordinarily powerful technique to identify
candidate molecules that participate in the process of mesoderm induction and patterning (Fig.i).
Originally, Nieuwkoop observed that animal pole explants (presumptive ectoderm), excised from
newt blastulae, would on their own differentiate into an atypical ciliated epidermis. However, when
apposed to vegetal pole explants, these cells would be diverted from their natural ectodermal
fate, and instead differentiate into mesodermal types, including muscle, mesothelium and
notochord. This experiment localized the source of the mesoderm inducing signal within the
vegetal pole (presumptive endoderm). Later experiments have searched for cell types or proteins
(either supplied in soluble form, or from synthetic, injected mRNAs), that would substitute for the
vegetal hemisphere in this assay, and convert presumptive ectoderm into mesoderm.
Two families of peptide growth factors have emerged as having the activity of primary
inducers in the animal cap assay (for review, see Jessell and Melton, 1992; Kimelman et al., 1992;
Sive, 1993). They are:
(i) Fibroblast Growth Factor (FGF) family members, such as acidic and basic FGFs, int-2 and kFGF
(FGFs 1, 2, 3 and 4, respectively), tend to induce ventro-posterior types of mesoderm
(mesothelium, muscle, and blood), but dorsal mesoderm such as notochord is not induced.
(ii) TGFI family members have distinct activities. As mentioned above, activins A and B are among
the most potent, and tend to induce antero-dorsal mesodermal cell types, including notochord
and muscle, and, by secondary induction, neural tissue. Amphibian animal caps treated with
activin can differentiate into small 'embryoids', where tissue types are arranged in a rudimentary
pattern that resembles natural body axes (Sokol et al., 1990). Activins are discussed further
below.
Another member of the TGF3 superfamily, Bone Morphogenetic Protein-4 (BMP-4), also
has mesoderm inducing activity on the presumptive ectoderm of the animal cap (Koster et al.,
1991; Dale et al., 1992; Jones et al, 1992). However, the mesoderm induced is of a ventral
character (mesothelium, red blood-like cells) while dorsal mesoderm (notochord, muscle)
induction is repressed. Interestingly, unlike FGFs, BMP-4 has a dominant effect on activin, being
able to override the response of animal caps to activin and to ventralize it. In whole embryos, BMP-
4 RNA injections inhibit formation of dorsal structures.
12
Part 1 Intro.
In addition to activins and BMP-4, yet another TGF3 superfamily member, the Vgl
peptide, was shown to have potent mesoderm inducing activity (Thomsen et al., 1993). In the
Xenopus oocyte and unfertilized egg, the mRNA for Vgl is localized to the vegetal pole, as
expected for the natural mesoderm inducer (Weeks and Melton, 1987). Mature Vgl peptide
induces a spectrum of mesoderm which is very similar to the one induced by activins. The
physiological function of Vg-1, however, remains unclear, since so far only the precursor
polypeptide was detected in embryos and the mature peptide could only be seen when a
chimeric BMP1-Vgl1 mRNA was introduced into the embryo.
1.4 The pleiotropism of activins
Like many cytokines, activins and their relatives inhibins (see below) are pleiotropic factors, and
their initial characterization stems from fields other than embryogenesis. They were first
recognized for their regulatory role on pituitary Follicle Stimulating Hormone (FSH) release. Activin
enhances FSH release from anterior pituitary cells in culture, whereas inhibin decreases it.
Activins modulate secretion of other pituitary and hypothalamic peptides (ACTH, GH and oxytocin)
as well. Furthermore, activins are potent inducers of erythropoietic differentiation and have been
implicated in inhibition of neural differentiation (for review, see Vale et al., 1990; Hemmati-
Brivanlou and Melton, 1994).
In adult vertebrate organisms, ovaries and testes are the major sites of expression of the
a, PA and 3B subunits of activin / inhibin (see 1.5 Structure of activins). In addition to the effects
on the pituitary, several intragonadal effects of activins and inhibins have been described. These
factors affect in an autocrine or paracrine manner the gonadal somatic cells, and in a paracrine
manner the germ cells themselves (reviews by Vale et al., 1990; de Jong et al., 1990; Mather et
al., 1992). Effects on proliferation, development of these cells, as well as on androgen
biosynthesis by the testicular Leydig cells or by the ovarian thecal cells were described, often with
activin and inhibin displaying opposite activities (see Table I for a summary of these effects; from
de Jong et al., 1990). The most definitive demonstration of an intragonadal effect of inhibin was
provided by disruption of the inhibin a gene by homologous recombination in mouse Embryonic
Stem (ES) cells (Matzuk et al., 1992). This study showed that mice lacking inhibin all develop, at a
few weeks of age, gonadal tumors of the sex-cord stromal type. Therefore inhibins are essential
regulators of growth for gonadal somatic cells. The role played by activins in the emergence of
these tumors is unknown, and is being investigated.
The variety of effects ascribed to these factors thus indicates that activins may participate
in early morphogenetic events, and are used again in the adult organism to regulate the growth
and differentiation of a wide variety of cell types.
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1.5 Structure of activins and their receptors
Activins are covalently linked 3p: homo- or heterodimers of PA and PB subunits (Fig. iii, after W.
Vale et al., 1990). The three activin ligands, activin A (PA:3A), activin AB (PA:PB) and activin B
(PB:PB) are thought to possess equivalent activities. A third subunit, inhibin a, can associate with
a p subunit to form an a:p dimer termed inhibin, and which often displays opposite biological
activity to activin (see below). Like other TGFP family members, the a, PA and OB subunits are
initially synthesized as precursors. The pro-regions play an essential role in intracellular assembly
of the dimer (Gray and Mason, 1990), and C-terminal proteolytic cleavage yields the disulfide-
linked mature peptides which constitute the biologically active ligand.
The mechanisms that underlie the antagonism of action of activins and inhibins are not
known. Mesoderm induction constitutes an exception to this effect as, in the animal cap assay,
inhibin (supplied as soluble factor) neither antagonizes activin nor has any effect of its own
(Asashima et al., 1990; Thomsen et al., 1990). An understanding of the mechanisms of action of
these peptides awaits further elucidation of their downstream effectors. Activin receptors belong
to a large family of receptors that include other TGFP superfamily member receptors (for a review,
see Kingsley, 1994). Each of these receptors results from the assembly of a type I and a type II
receptors, which exist in multiple isoforms. Both type I and type II receptors display a Serine-
Threonine kinase motif. The patterns of ligand-receptor specificity in this family appear complex,
and in some cases 'cross-talk' between various TGFO family members and the receptors exists. In
a given receptor, the type II partner is involved in specifying ligand identity, and the type I partner
is involved in signal transduction (Kingsley, 1994; Wrana et al., 1994). Activins are known to bind
to the products of two genes, ActRIIA and ActRIIB, and several activin type I receptors exist.
Inhibin receptors are less well characterized, but are expected to belong to the same family.
1.6 Expression of activins in embryos
Supporting their role in early morphogenesis, activins are expressed in vertebrate embryos,
starting from very early stages (Table II). In Xenopus, an activin bioactivity of unknown identity can
already be detected in the unfertilized egg and in the blastula embryo (Asashima et al., 1991)* .
Zygotic expression is detected in the late blastula for the PB subunit, and in the late gastrula for
the 3A subunit (Thomsen et al., 1990). Similarly, activin 3B expression precedes activin PA
expression in both chick and fish early embryos (Mitrani et al., 1990; Wittbrodt and Rosa, 1994).
* Recently, activin A, AB, and B proteins were demonstrated to be present in early Xenopus
embryos (stage 1-5) (Fukui et al., 1994).
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In the mouse as well, development is initiated in the presence of activins, both maternal
and embryonic in origin (Table III). Albano et al. (1993; 1994) have analyzed activin expression in
mouse embryos, before and after implantation. They found that activin protein was present during
all stages of preimplantation development, whereas inhibin was absent. At the RNA level, both 3A
and 1B subunit RNAs were present as maternal messages in the oocyte, were degraded after
fertilization, and reappeared as embryonic RNAs in the morula. The early postimplantation
embryo, however, lacked both 1A and 1B subunit RNAs. At this time, in contrast, the maternal
uterine decidual tissue expressed activin subunits to a high level: 1A RNA was found from as early
as day E5.0 in the decidua surrounding the whole embryo, and PB RNA was located more
specifically around the ectoplacental cone (Manova et al., 1992; Albano et al., 1994; Feijen et al.,
in preparation). Intense decidual expression, in the context of a lack of expression within the
embryo at the time of mesoderm formation, led Manova et al. (1992) and others to speculate that
the source of activins in mammalian embryos may have shifted from embryonic to maternal.
In later mouse embryos, using RNA in situ analysis, activin subunit RNAs are first detected
weakly in the heart at day E8.5, and become more abundant, each in distinct and specific
locations, starting at day E10.5 (Albano et al., 1994). Feijen et al. (in preparation) have performed
a detailed study of the sites of expression in postimplantation mouse embryos from day E6.5 to
day E13.5. They have found that in mid-gestation embryos, 1A RNA is found in mesenchyme of
the face, body wall, heart, precartilage condensations of the limbs, and in mesenchyme of the
digestive, respiratory and genital tracts.
13B RNA shows a distinct expression pattern. It is strongly expressed in selected regions of the
brain, in particular in ependymal layers where cells have high mitotic activity, and in the spinal cord.
13B RNA is also found in the epithelium of the oesophagus and stomach, and in mesenchymal
condensation of the developing eye. Common sites of 13A and 1B expression are in blood
vessels, intervertebral disc anlagen, mesenchymal condensation of the flank region, and in the
gonad primordium. As the a subunit mRNA is only found in the gonad primordium, inhibin
production is thought to be restricted to that tissue.
1.7 Working hypothesis and strategy
A genetic dissection of mesoderm formation in the mouse requires the availability of mutants in
the endogenous inducer genes, and the elucidation of their interactions with other genes and
mutants on this pathway.
Two genes involved specifically in mesoderm formation were identified by the virtue of
the existence of a mutation in the locus:
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- Brachyury (T) homozygous mutant embryos show abnormal mesoderm formation and migrative
properties, and an absent or deficient notochord. The T gene product is a nuclear, DNA-binding
protein, that presumably acts as a transcription factor (Kispert and Herrmann, 1993).
- nodal (413.d) mutant embryos have a defect in the establishment or maintenance of the primitive
streak, do not form a mesoderm germ layer and lack a-p polarity. The gene product was identified
(Zhou et al., 1993) as a TGFP-like peptide, related to the BMP family. The in vitro activity of the
nodal protein has not been described yet but the mutant phenotype suggests that it is a central
player in mesoderm formation.
In addition, several gene targeting experiments have identified genes involved in the elaboration
of mesoderm in the mouse. For instance, the Wnt-3a gene, which encodes a putative intercellular
signaling molecule, was shown to be involved in the specification of somite fate, and essential in
establishment of the tailbud or its maintenance (Takada et al., 1994). The tailbud is the site of
emergence of new mesoderm after day E9.5. As a consequence, mutant embryos lack caudal
somites and their body is truncated posterior to the forelimb. These mutations provide genetic
and molecular tools for an analysis of gene interactions in early development.
As discussed above, activins (and especially activin B) appear to be good candidate
embryonic morphogens in light of:
1) their in vitro activities as mesoderm inducers in amphibians, and in particular the ability to evoke
dose-dependent, stepwise transitions in cell fates that mimic cell fates along a body axis,
2) their ability to induce a series of immediate-early response genes, which themselves are
thought to play important roles in early patterning, as T (Brachyury), goosecoid, and several fork
head genes (Fig. ii); and
(3) the observation that they are expressed in early embryos of a variety of vertebrates (fish,
Xenopus, chick, and mouse).
I have cloned the mouse genes for the two subunits of activins (PA and PB), in the goal of
generating mouse lines deficient in these factors. Because the JB subunit gene is expressed
earlier in frog and chicken embryos, the OB mutant was generated initially. Following is a
description of the generation and analysis of the OB deficient mice (Vassalli et al., 1994). The
intercross of these mice with PA deficient mice to generate mice lacking all activins and inhibins is
then described (Matzuk et al., in press).
16
(I)
0
* - mm---- -OxCL
U.. c 0 l < < n
0 <
Ui > 1 E
o-
a) 0U) -U
E 
-
* -I 0 o: .)
0
oo 7
0E0 E= oa=i tE z-• C
r"-L __
QL. E
EE
c E1 o-·a,
tr,
Figure ii.
Activin Immediate-early Response Genes:
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TABLE I. EFFECTS OF INHIBIN
SYSTEMS (from de Jong et al.,
Organ
Parameter
AND ACTIVIN ON NON-PITUITARY CELL
1990).
-------- Effects of--------
Inhibin Activin
Hypothalamus
Oxytocin secretion
Testis
Testosterone production
Spermatogonia
Ovary
Granulosa cells
LH-receptor
FSH-receptor
Estradiol
Progesterone
Inhibin
Oocytes
Meiotic division
Placenta
GnRH; HCG
Hematopoietic cells
Colony formation
Cell differentiation
Cell proliferation
Fibroblasts
Proliferation
Pancreas, liver
Insulin secretion
Glycogenolysis
n.d.
n.d.
n.d.
n.d.
n.d.
+
n.d.
n.d.
+
+
+
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
+, stimulatory effect; -, inhibitory effect; =, no effect detected; n.d., not
determined. Data are compiled by de Jong et al. (1990) from many primary
sources.
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Abstract
Inhibins and activins are dimeric growth factors of the transforming growth factor-P superfamily, a
class of peptides that can regulate the growth and differentiation of a variety of cell types. Recently,
activins have been implicated in early vertebrate development through their ability to evoke, in
Xenopus embryo explants, both morphological and molecular changes characteristic of mesoderm
induction. To understand these processes further, we have used homologous recombination in
embryonic stem cells to create mouse strains carrying mutations in the gene encoding the
activin/inhibin OB subunit. These mice are expected to be deficient in activin B (1B:0B), activin AB
(PA:3B) and inhibin B (a:PB). Viable mutant animals were generated, indicating that the 3B subunit is
not essential for mesoderm formation in the mouse. Mutant animals suffered, however, from distinct
developmental and reproductive defects. An apparent failure of eyelid fusion during late embryonic
development led to eye lesions in mutant animals. Whereas 3B deficient males bred normally, mutant
females manifested a profoundly impaired reproductive ability, characterized by perinatal lethality of
their offspring. The phenotype of mutant mice suggests that (1) activin PB plays a role in late fetal
development and (2) is critical for female fecundity. In addition, we have found that expression of the
related PA subunit of activin is highly upregulated in ovaries of mutant females. Altered regulation of
PA activin in 1B deficient mice may contribute to the mutant phenotype.
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Introduction
Candidate genes and proteins that govern the formation and patterning of the mesoderm in vertebrate
embryos have recently emerged. Through studies in amphibians came the realization that specific
polypeptide growth factors were able to reproduce some aspects of mesoderm induction in embryo
explants. These factors include members of the transforming growth factor-P (TGF-P) superfamily
such as activins A and B, bone morphogenetic protein 4 (BMP-4) and Vg-1, and members of the
fibroblast growth factor (FGF) family such as basic FGF (Kimelman and Kirschner, 1987; Slack et al.,
1987; Asashima et al., 1990; Smith et al., 1990; Thomsen et al., 1990; van den Eijnden-Van Raaij et
al., 1990; Koster et al., 1991; Dale et al., 1992; Jones et al., 1992; Thomsen and Melton, 1993) . In
addition, other factors that do not have the ability to induce mesoderm from presumptive ectoderm by
themselves, were found to modify the pattern of mesodermal differentiation evoked by an inducer.
These include members of the Wnt family such as Xwnt-8, and noggin (Smith and Harland, 1991;
Sokol et al., 1991; Smith and Harland, 1992; for reviews see Kimelman et al., 1992; Sive, 1993).
Among mesoderm inducing molecules, activins are unique because of their ability to induce a full
range of mesodermal fates, from anterior-most mesoderm (organizer) to tail, in a concentration-
dependent manner (Green et al., 1992). Genes induced by activins as an immediate-early response
were identified and include the organizer-specific goosecoid gene and the Brachyury gene (Cho et al.,
1991; Smith et al., 1991). In the Brachyury mouse, mesoderm formation is defective. Cloning of the
mouse Brachyury (T) gene (Herrmann et al., 1990) has provided the first identification of a gene
located on the pathway of mesoderm formation in vertebrates. As inducers of Brachyury, activins are
thought to be part of this pathway as well. Animal caps induced by activin also undergo
morphogenetic cell movements that are characteristic of gastrulation (Smith and Howard, 1992). Thus
histological, molecular and cell behavior responses of animal cap explants to activin recapitulate
many aspects of gastrulation. Hemmati-Brivanlou and Melton (1992) have provided the most
compelling evidence of the involvement of an activin-like molecule in mesoderm formation by showing
that injection of an mRNA encoding a truncated activin receptor into Xenopus embryos interferes with
activin signaling and prevents mesoderm induction.
Activins are structurally related to the inhibin class of peptides. Inhibins were initially isolated
from mammalian follicular fluid on the basis of their ability to inhibit the release of follicle stimulating
hormone (FSH) from anterior pituitary cells (for review, see Vale et al., 1990). In the course of inhibin
purification, side fractions that instead stimulated FSH release lead to the identification of activins
(Ling et al., 1986; Vale et al., 1986). Inhibins and activins are dimers assembled from subunits
encoded by three distinct genes: the a, 3A and PB subunit genes. The precursor polypeptides
encoded by these genes are proteolytically processed into mature peptides, whose dimers form the
biologically active molecules. Inhibins are a:p heterodimers, whereas activins are p3: homo- or
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heterodimers. The two P3 subunits, P3A and 1B, share within a species -60% sequence identity,
whereas the a subunit is more distantly related. Each P3 subunit is highly conserved across species
and >98% identical between mammalian species (Vale et al., 1990). The PB subunit is expressed in
Xenopus (Thomsen et al., 1990) and chick (Mitrani et al., 1990) late blastula embryos. In the mouse,
I3 subunit mRNAs and f3 subunit immunoreactivity, in the absence of a subunit expression, were
demonstrated during preimplantation stages, indicating the presence of activin in the pre-gastrulation
mouse embryo (van den Eijnden-van Raaij et al., 1992; Albano et al., 1993).
In adult animals, highest expression levels of activin/inhibin subunits are found in the gonads.
Recent evidence implicates inhibins and activins as intragonadal paracrine and/or autocrine
regulators (reviewed by de Jong et al., 1990; Mather et al., 1992; Findlay, 1993). The major sites of
inhibin/activin expression are the Sertoli cells of the testis and the granulosa cells of the ovary.
Inhibins and activins were found to affect both the germ cells and the somatic components of the
gonads. Activin can stimulate spermatogonial proliferation, whereas inhibin has the opposite activity.
Isotypes of activin receptors were detected on specific populations of male germ cells (Kaipia et al.,
1992; Kaipia et al., 1993), suggesting that these factors play a role in the regulation of
spermatogenesis. Furthermore, androgen biosynthesis in testicular Leydig or ovarian thecal cells is
inhibited by activin and enhanced by inhibin. In females activin and inhibin were suggested to either
stimulate or inhibit, respectively, oocyte meiotic maturation, and to affect follicular development. The
most conclusive evidence for a critical role of inhibin as a regulator of proliferation of somatic
components of the gonad was provided by the finding that inhibin deficient mice generated by a
subunit gene targeting develop gonadal stromal tumors at a very early age (Matzuk et al., 1992).
Other studies have revealed extragonadal sources of inhibin and activin synthesis and
demonstrated responses in a variety of cell types (Meunier et al., 1988; Vale et al., 1990). Thus,
activins have been implicated in inhibition of neural differentiation (Hashimoto et al., 1990; Schubert
et al., 1990; van den Eijnden-van Raaij et al., 1991; Hemmati-Brivanlou and Melton, 1992), and
induction of erythropoietic differentiation (Murata et al., 1988). In addition to their action on FSH
release, their ability to regulate secretion of other hypothalamic or pituitary peptides such as oxytocin,
ACTH and GH was shown (Vale et al., 1990).
To study the physiological role of these factors in mouse development and reproduction, we
have used homologous recombination in embryonic stem (ES) cells to create mutant alleles where
most of the first coding exon of the PB gene was deleted, and these mutations were introduced into
the germline of mice. Although it remains to be seen whether embryonic development proceeds
normally at a molecular level in OB deficient animals, they are born without major morphological
abnormalities, with the exception of a defect in eyelid outgrowth and closure. The generation of viable
mutant animals has, however, revealed a critical role for activin/inhibin 13B in female reproductive
function.
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Results
Mice homozygous for a targeted mutation in the activin/inhibin fB subunit gene are viable
The mouse activin/inhibin PB subunit gene was isolated from a genomic DNA library derived from the
129/Sv strain using a rat partial cDNA as a probe (rinB-c2-P; Dr Kelly Mayo, unpublished). Location of
the coding exons is diagrammed in Figures 1A and 1 B. Two replacement type targeting vectors
termed pBB1 and pBB2 (Fig.1 B) were used to disrupt the OB subunit gene by homologous
recombination (Thomas and Capecchi, 1987). Each vector contained 15.5 kb homology with the
cognate gene. These constructs were designed to replace a 1.3 kb region of the 3B subunit locus
spanning the translational start codon, the signal peptide coding region as well as most of exon 1-
encoded pro-region sequences with a PGK promoter driven neo selection cassette containing a PGK
poly(A) signal (PGK-NEO-p(A)) (McBurney et al., 1991). The pBB1 construct contained the PGK-
NEO-p(A) cassette in the same transcriptional orientation as the 3B gene and the pBB2 construct
contained it in reverse orientation. J1 ES cells (Li et al., 1992) were electroporated with linearized
DNA and selected with G418. Homologous recombinant ES cell clones were identified by Southern
blot analysis of genomic DNA from individual clones (see Materials and Methods). Both targeting
constructs demonstrated similar, high frequencies of recombination at the endogenous OB subunit
locus (Table 1).
Three independent ES clones heterozygous for the BB1 mutation and one clone
heterozygous for the BB2 mutation were injected into host blastocysts to generate chimeric founder
mice. All four clones contributed to the germline of chimeric animals, permitting the derivation of
several independent mouse lines carrying the mutant alleles. Mice heterozygous for either the BB1 or
BB2 mutation did not display an overt phenotype. To evaluate the possibility that the genetic
background influences the mutant phenotype, animals heterozygous for the BB1 mutation were bred
to homozygosity on three different genetic backgrounds. Genotype analysis of weanling offspring
(Table 2) revealed that homozygous mutant animals with a 129/Sv X C57BL/6 hybrid genetic
background were only marginally compromised in their viability, if at all, as they represented 21 % of
the animals genotyped, instead of the expected 25 %. In the 129/Sv X BALB/c hybrid background,
however, the fraction of homozygous mutants was lower (Table 2), suggesting that alleles in the
BALB/c background may interact with the activin mutation and reduce viability. These results
therefore indicated that mice homozygous for the BB1 or BB2 mutation are viable, although their
viability may be affected by the genetic background.
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Mutant mice lack wild-type mRNA and mature fB peptide
To examine how the BB1 mutation affects transcription at the 1B locus, RNA was prepared from
ovaries and testes of immature (3-week) or adult animals and subjected to reverse transcription
followed by the Polymerase Chain Reaction (RT-PCR). When oligonucleotide primers that span the
mature peptide coding region were used, a OB-specific band of the expected size was obtained both
in mutants and in controls. In addition, primers that span the intron amplified the expected 1B-specific
band in mutant animal tissue, although with markedly reduced efficiency relative to controls (data not
shown). These results indicated that transcription downstream of the neo insertion occurred in the
BB1 allele. This is not unexpected as the PGK poly(A) site was previously shown to allow
readthrough transcript accumulation (e.g., Lee et al., 1992).
To characterize further the nature of the transcript produced by the BB1 mutated allele,
Northern blot analysis was performed (Fig. 2). The two probes used were the mACT10/11;13 probe, a
PCR-generated fragment corresponding to the mouse PB mature peptide region (Fig.2A and see
Materials and Methods), and a neo probe (Fig.2B). A -4.5 kb transcript corresponding to the major
wild-type mRNA (Albano et al., 1990; Manova et al., 1992) was detected with the mACT10/11;13
probe in (+/+) and (+/bbl), but not in (bbl/bbl) ovaries. In wild-type animals, a minor ovarian
transcript of -3.5 kb could be detected, but never in (bbl/bbl) animals. The 3.5 kb transcript was also
seen in wild-type testes, approximately equimolar to the 4.5 kb transcript, as reported previously
(Feng et al., 1989a). Neither the 4.5 nor the 3.5 kb transcripts were detected in the (bbl/bbl) mutant
testes. The mACT10/11;13 probe however detected a novel transcript of -4.0 kb in both testes and
ovaries of animals containing a mutated BB1 allele, but not in (+/+) animals. The neo probe also
hybridized to a band of the same size. Therefore, the 4.0 kb transcript likely corresponds to a neo-PB
chimeric transcript, reading through the PGK poly(A) site and terminating at one of the 3B gene
endogenous poly(A) sites. Because the promoter(s) and poly(A) site(s) of the mouse 3B gene have
not been mapped, it is not possible to predict the exact size of such a chimeric transcript. As
expected, a major -1.0 kb band corresponding to a transcript initiated at the PGK promoter and
terminated at the PGK poly(A) site was detected by the neo probe in (bbl/bbl) and (+/bbl) animals.
As determined with the neo probe, the 4.0 kb neo-PB readthrough transcript was -1/10 as abundant
as the neo transcript terminated at the PGK poly(A) site. Examination of RNA from animals
homozygous for the BB2 allele likewise showed the absence of the wild-type transcripts and revealed
the production from this allele of a new transcript of -3.0 kb that did not hybridize to the neo probe
(Fig.2), consistent with its initiation within the PGK promoter (used in reverse orientation) and its
termination at an endogenous 1B poly(A) site.
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In order to establish whether the aberrant transcript made by the BB1 allele could produce OB
peptide, we next performed protein blot analysis. OB-specific antibodies (Vaughan et al., 1989) could
readily detect a -12 kD peptide in ovarian tissue from heterozygous or wild-type weanling females
(Fig.3, upper panel, lanes 6, 7, 9, 10 and 12-14), but not in tissue from (bbl/bbl) mutant females
(lanes 4, 5, 8 and 11). A polypeptide of MW -50 kD, consistent with the OB precursor size, was also
detected by the PB-specific antibodies in gonadal extracts from wild-type or heterozygous animals,
but was absent in homozygous mutants (not shown).
In summary, the results of Fig.2 and 3 indicate that the BB1 mutant allele does not yield
productive PB subunit mRNAs capable of generating the mature OB peptide whose dimer with another
p subunit or with an a subunit forms the biologically active activin or inhibin ligand. (bbl/bbl) mutant
animals are therefore expected to lack activins B and AB, as well as inhibin B , but their ability to
produce activin A and inhibin A should be preserved.
The PB deficient ovary upregulates expression of the PA subunit
Expression of the activin/inhibin PA mature peptide was investigated in total ovarian tissue extract
from 3-week old females. This analysis revealed a 3 to 20-fold increase in levels of JA mature peptide
in animals homozygous for the BB1 mutation, relative to their heterozygous or wild-type littermates
(Fig.3, middle panel, compare e.g. lanes 4,5 to lanes 6,7). In the same ovarian extracts, anti-a inhibin
subunit antibodies recognized a -45 kD polypeptide whose levels were not altered by the PB mutation
(Fig. 3, lower panel).
Overexpression of the PA subunit in the PB deficient ovary may reflect altered development
and cellular architecture of the mutant tissue, leading to an overrepresentation of PA expressing cells.
Alternatively, regulatory mechanisms that sense the 3B deficiency may exist and cause a
compensatory increase in PA subunit expression.
To analyze this effect further, PA subunit RNA expression was examined by Northern analysis
of ovarian extracts from immature animals. No consistent alterations in levels of the -7.0 kb mRNA
were observed in mutant tissue (not shown). Therefore, a posttranscriptional mechanism may operate
to upregulate PA mature peptide production in the jB deficient ovary.
Failure of eyelid fusion at birth
Upon intercrossing animals heterozygous for the BB1 (or BB2) mutation we observed that a fraction
of the neonates in the resulting litters had a distinctive phenotype. Normally, mouse pups are born
with closed eyes due to fusion of the eyelids at embryonic day 16 (E16) (Rugh, 1990), and eyes open
again only at -13 days of postnatal life. In contrast, a fraction of the offspring from heterozygous
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parents were born with open eyes, as illustrated in Fig. 4 A and B. All the open eyed neonates
derived from four independent ES cell clones carrying either the BB1 or BB2 mutation and genotyped
at birth by Southern analysis were homozygous for the mutant allele. Not all homozygotes, however,
showed this phenotype, suggesting incomplete penetrance (see below). To determine whether the
structure of the eye was otherwise affected in the mutant newborns, histological sections through the
heads of (bbl/bbl) mutant animals and (+/bbl) control littermates were examined (Fig. 4 C, D, E).
The general anatomy of the eye of the mutant newborns appeared normal, indicating a defect
confined to the eyelids. Animals born with open eyes quickly developed a number of eye defects,
which likely reflected traumatic damage due to the lack of eyelid protection. Hyperkeratinisation and
squamous metaplasia of the corneal epithelium, accompanied by massive leukocyte infiltration of all
cornea layers and eyelids, were observed as soon as the first day of life. During the subsequent days,
eyelids often sealed. The timing of eye reopening appeared then delayed in mutants and revealed
permanent damage that included ocular dystrophy and opacification of the cornea. This macroscopic
eye pathology allowed ready identification of mutant animals during adulthood.
The open eyelid phenotype of the BB1 mutation was found to depend on the genetic
background (Table 3). In the original mouse line 43, F1 animals had been backcrossed once to
C57BL/6 and then intercrossed. In this line, the fraction of homozygous mutant animals exhibiting
obvious eye defects during adulthood was 0.84 (N=89). A similar phenotype was observed in a
129/Sv X BALB/c hybrid genetic background, although with reduced penetrance. In contrast, when
the BB1 mutation was present in a 129/Sv inbred background, the failure of eyelid fusion was never
observed: none of the pups born from heterozygote intercrosses (N=137), or born from homozygous
mutant males mated to heterozygous females (N=69), had open eyes at birth, and among 14 adult
mutant animals, none had eye defects. This suggests that the 129/Sv inbred strain carries a gene (or
genes) that suppress the open eyelid phenotype caused by the BB1 mutation. Segregation of such
129/Sv specific suppressor genes may also explain the incomplete penetrance of the phenotype in
the two hybrid genetic backgrounds. Furthermore, the expressivity of the phenotype varied among
affected individuals, with various degrees of completion of eyelid fusion at birth or, occasionally, a
single eye being affected.
Mutant females manifest a reproductive impairment
Activins and inhibins are thought to be regulators of reproductive functions through their influence on
both the pituitary and the gonads. Therefore, we next evaluated the fertility of the BB1 homozygous
mutant animals. The viability of homozygous mutant embryos had also raised the possibility that
maternal supply of OB peptide might rescue the potential defect in mutant embryos. If this were the
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case, mutant females might be expected to be impaired in sustaining normal pregnancy and delivery
of live pups.
To assess reproductive performance, we bred (bbl/bbl) mutant animals of either gender with
heterozygous mates, and intercrossed homozygous mutant animals or heterozygous littermates. The
average number of viable offspring per breeding pair and per month of breeding was determined for
each type of cross. Fig.5 summarizes the reproductive performances observed. Homozygous mutant
males bred as well as their heterozygous littermates when mated to heterozygous females. In sharp
contrast, homozygous mutant females mated to either heterozygous or homozygous mutant males
manifested a profoundly reduced ability to generate live offspring as compared to their heterozygous
littermates. Histological examination of ovaries from PB deficient females did not show overt
abnormalities (data not shown). The reproductive impairment of mutant females did not result from
defective oogenesis, inability to undergo fertilization or development of embryos in utero, because
they became pregnant at a frequency similar to their heterozygous littermates. Reduced fertility
appeared rather to result from perinatal loss of the progeny. Offspring were born from mutant females
but rarely survived beyond 24 hrs postpartum. A common observation on the day of delivery was
death of an entire normal-sized litter.
There was no excess of phenotypically mutant animals among the pups dying perinatally.
Consistent with this, we observed no distortion of genotypes among the rare pups that survived the
perinatal period: of 21 weanling mice born from (bbl/bbl) mutant females mated to heterozygous
males, 10 were (bbl/bbl) and 11 were (+/bbl). Thus, neonatal lethality appears unaffected by the
genotype of the offspring but rather reflects a maternal defect.
Female reproductive failure was observed in lines of mice derived from three independent ES
cell clones, and was manifest in the three genetic backgrounds tested: in inbred 129/Sv background,
and in the two hybrid backgrounds (129/Sv X C57BL/6 and 129/Sv X BALB/c, after one backcross to
C57BL/6 or BALB/c, respectively). 129/Sv X BALB/c hybrid mutant females appeared the most
seriously affected: a total of 10 pregnancies carried by 4 different females failed to generate live
offspring.
Mutant females show increased gestation time and decreased nursing ability
In staged matings where the day of vaginal plug (E0.5) was recorded, OB deficient females were
observed to show an increase in the average duration of gestation. Among 13 control sibling females
(heterozygous or wild-type), 8 had delivered the morning of day E19.5 and all but one had delivered
by the afternoon of that day. In striking contrast, none of 12 mutant females delivered on day E19.5.
Most mutant females delivered on day E20.5, and some in the morning of day E21.5. Occasionally,
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initiation of labor appeared to fail altogether, resulting in sickness of the gravid mother, and death of
fetuses in utero.
Delivered babies that were about to die were morphologically unremarkable, but were cold
and had empty stomachs, suggesting that their death was due to a maternal failing. Lactogenesis,
however, occurred in mutant females. Histological analysis of mammary glands in a pair of control
and mutant siblings at -0.5 day postpartum is shown in Fig.6. Accumulation of milk in lobules and
ducts of mutant tissue is evident. These observations suggest that either milk let-down is impaired or
that the babies fail to suckle. The former possibility is supported by preliminary data showing that
offspring born from mutant females and not nursed can be rescued by fostering to a normal female
(not shown).
FSH measurements in mutant animals
To analyze further the cause of the reproductive defect in mutant females, and to determine
whether pituitary function was altered in PB deficient animals, serum FSH levels were measured
(Table 4). The interpretation of these data was complicated by the facts that (a) FSH values fluctuate
widely within an experimental group, and (b) an age-dependent increase in FSH values was evident
in adult animals from 11 to 24 weeks of age. Nevertheless, this study revealed an approximately 20 %
increase in average serum FSH levels in mutant animals relative to heterozygotes, and the increase
was consistent in all groups analyzed. It thus appears that in the context of a deficiency in both
activins B, AB (which enhance FSH release in vitro) and inhibin B (which decreases it), the effect of
inhibin deficiency is slightly dominant. The physiological significance of this modest elevation in
circulating FSH is unknown.
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Figure 1. Mutagenesis at the Activinllnhibin PB Subunit Locus of Mice. 1A, Exon
structure of the PB subunit gene showing the region deleted in the BB1 and BB2 mutant
alleles. The transcription start and polyadenylation sites have not been mapped, and
therefore the corresponding exon boundaries are indicated with dashes. The striped box
indicates the coding region for the mature 1B peptide. Note that the 5' splice site at the end
of the first coding exon is left intact in the BB1 and BB2 recombinant alleles. Not all Narl
sites within the 1.3 kb deleted fragment are represented. 1B, Targeting scheme. A
physical map of the locus is shown at the top. The structure of the targeting constructs is
indicated below. Dashed lines delineate regions of homology with the chromosome. The
new EcoRI site introduced by the mutation is indicated in each targeting vector. The pBB2
vector is identical to pBB1, except that the orientation of the neo cassette is reversed.
Probe E is the external probe used to screen ES cell colonies and to genotype mice. rinB-
c2-P represents the rat cDNA probe used to isolate genomic DNA from the PB locus. 1C,
Southern blot analysis of DNA from offspring produced by heterozygote intercrosses.
DNA was digested with EcoRI and hybridized to probe E. Molecular weight markers (in
kb) are shown on the right. Restriction sites : B, Bglll; R, EcoRI; N, Narl; Nc, Ncol.
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Figure 2. RNA Analysis in OB Mutant Animals. Total RNA from ovaries (-10 ug, lanes
1 to 5), testes (20 ug, lanes 6 to 8), and uterus (20 ug, lanes 9 to 11) from individual
animals were examined by RNA blot analysis using a probe corresponding to the PB
mature peptide encoding region (mACT1011 ;13, panel A) or a neo probe (panel B).
Genotypes of animals are indicated at the top and positions of ribosomal RNAs are
shown on the right.
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Figure 3. Animals homozygous for the BB1 mutation lack mature 3B peptide and
upregulate PA peptide expression. Ovarian extracts from individual immature (21-day
old) females were run on a SDS-PAGE gel under reducing conditions and examined by
immunoblot analysis using anti-PB antibodies (upper panel). These antibodies recognize
a peptide in the C-terminal region of the OB subunit. The same blot was stripped and re-
analyzed using anti-PA antibodies (middle panel) or anti-a antibodies (lower panel).
Lanes 1 to 3 contain 1 ng each of human recombinant inhibin A (lane 1), activin A (lane 2),
activin B (lane 3). Lanes 4 to 14 contain 100 ug each of total protein from ovary.
Genotypes are indicated at the top. Lanes 13 and 14 represent a control wild-type
129/Sv, and a control wild-type C57BL/6 female, respectively. Extracts in lanes 4 to 7
originate from siblings with a 129/Sv X BALB/c hybrid genetic background (BALB-N2
backcross), lanes 8 to 10 are from siblings with a 129/Sv X C57BL/6 background (B6-
N1), and lanes 11 and 12 are from siblings from a (129/Sv X C57BL/6) N4 backcrossed
generation. Migrations of molecular weight markers (in kD) are shown on the left.
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Figure 4. Failure of Eyelid Closure at Birth. A, a heterozygous control
pup showing fused eyelids covering the eye, B, homozygous mutant littermate
with open eyelids. Photographs in A and B were taken within a few hours of
birth. C, D, E, Transverse sections through the eyes of (C) a heterozygous
control neonate; an arrow indicates the site of eyelid fusion, (D) a mutant
neonate a few hours after birth, before inflammation is evident, and (E) a mutant
neonate at -0.5-1 day of age, displaying acute leukocyte infiltration in the
cornea and eyelids, corneal edema and corneal hyperkeratinization. Objective
magnification was 10 X.
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Figure 6. Postpartum Histology of Mammary Glands in Mutant and
Control Heterozygote Siblings. Panels A and C show control tissue from a
heterozygous female and panels B and D show tissue from a mutant 0B
deficient sibling. Tissue was taken -0.5 day after delivery. Note the increased
glandular:adipose tissue ratio, the accumulation of milk and the vacuolation of
lobules in mutant mammary tissue. The mutant animal had delivered a litter that
was not nursed. Both animals were from a BALB-N1F2 generation. Objective
magnification was 4X (A and B), and 20X (C and D).
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Discussion
We have created mouse lines carrying two different mutant alleles for the gene that encodes the
activin/inhibin PB subunit. In both alleles the coding capacity (in exon 1) for approximately a third of
the PB precursor polypeptide was deleted at its N-terminal. Gray and Mason (1990) have shown that
the pro-region of the activin A precursor is essential for the intracellular assembly of the homodimer
and secretion of biological activity. It is not known where the dimerization activity resides within the
pro-region and whether the exon 2-encoded pro-region would suffice in this function. It is likely,
however, that the alteration generated loss-of-function alleles because the signal sequence and
approximately half of the propeptide sequence were deleted. Protein analysis confirmed the lack of
mature PB peptide in mutant tissue. The mutation, therefore, should prevent the synthesis of activins
B, AB and of inhibin B. Nevertheless, mutant mice completed embryonic development and were
viable. Their birth with open eyes indicated, however, that some aspects of development were altered
in the absence of a wild-type OB subunit gene. The generation of viable mice has furthermore
uncovered a maternal effect by which maternal PB chain expression is required for efficient perinatal
survival of newborns. As a result, OB deficient females had an extremely low fecundity, despite their
ability to sustain gestation up to the time of birth.
Recent evidence implicates an activin-like molecule as a patterning morphogen during early
vertebrate development (reviewed by Kimelman et al., 1992; Sive, 1993). Remarkably, interference
with the activin pathway by injection of an mRNA encoding a truncated activin receptor into Xenopus
embryos prevents mesoderm induction and formation of axial structures (Hemmati-Brivanlou and
Melton, 1992). Of the two activin genes, the PB subunit gene is the first expressed in Xenopus
(Thomsen et al., 1990; Dohrmann et al., 1993) and chick embryos (Mitrani et al., 1990) which has led
to the hypothesis that activin B may be involved in mesoderm induction. Activin activity is already
detectable in the unfertilized Xenopus egg (Asashima et al., 1991), but zygotic expression occurs only
at the late blastula stage (Thomsen et al., 1990). Thus, it is not clear whether activins are involved in
the induction of mesoderm itself or rather in patterning and regionalization of already induced
mesoderm. In the mouse embryo, activin OB specific RNA as well as activin P subunit protein have
been detected in blastocysts and at cleavage stages, respectively (van den Eijnden-van Raaij et al.,
1992; Albano et al., 1993). Survival of OB mutant mice to adulthood, therefore, indicates that activins
B, AB and inhibin B are dispensable for embryonic development in the mouse. Matzuk et al. (1992)
have previously shown that a subunit deficient mice, lacking inhibins A and B, develop to term. These
molecules may not play a function in early mouse development, or there may exist overlapping
pathways allowing compensation for their deficit at these stages. The 3A subunit gene in particular
may 'cover' the OB deficiency in our mutants. Our finding of upregulated expression of the PA subunit
in the PB deficient ovary possibly reflects a regulatory mechanism that also operates in the mutant
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embryo and provides a means for normal morphogenesis in the absence of activin B. Generation of
an activin-less mutant by targeting the 1A gene and intercrossing PA and OB mutant mice should
provide definitive answers to some of these questions. In addition, examination of the expression of
activin immediate-early response genes, as Brachyury and goosecoid, in the OB deficient embryos
should help to determine whether development proceeds normally, both temporally and spatially.
Although OB subunit mutant embryos develop to term, the deficiency in either activin B,
activin AB or inhibin B affects prenatal development, as revealed by a defect in eyelid fusion at birth.
Inhibin deficient mice are born with closed eyes, suggesting that the open eye phenotype specifically
results from activin deficiency. Unfused eyelids at birth could result from either premature (prenatal)
eye opening or, perhaps more likely, from failure of fusion at E16. The event of eyelid closure
depends on the proliferation of mesenchymal cells to effect apposition and eventual fusion of the
eyelids at E16. These cells are neural crest derivatives that populate the first branchial arch (see
Juriloff and Harris, 1993). The significance of the open eye phenotype is unclear. A variety of
mutations are known to cause birth with open eyes in mice (Lyon and Searle, 1989). Some reside at
unknown loci and others result from targeted disruption of specific genes. The latter category includes
mutants in the c-abl and TGF-a genes (Schwartzberg et al., 1991; Luetteke et al., 1993; Mann et al.,
1993). The variety of primary defects causing open eyes at birth suggests an unspecific nature to this
phenotype. The process of eyelid outgrowth and fusion may be especially sensitive to sublethal
developmental perturbations. For example, it may rely upon events that can only occur in a narrow
window of time. Alternatively, as suggested by the fact that the genes for both the OB subunit and an
activin receptor are expressed in the eye anlagen of Xenopus embryos (Dohrmann et al., 1993), a
more specific effect of OB on the eye may be operating. A different mutation in the PB subunit gene,
that results in deletion of part of the mature peptide encoding region, was also found to affect eyelid
fusion in mouse embryos (H. Schrewe and T. Gridley, personal communication).
Expression of the eye phenotype was affected by the genetic background. The defect was
never observed in 129/Sv inbred mice but was seen when the mutation was introduced into either of
two hybrid genetic backgrounds (129/Sv X C57BL/6 or 129/Sv X BALB/c). The incomplete penetrance
observed in hybrid mice may therefore be due to the existence of suppressor allele(s) contributed by
the 129/Sv genome. Further backcrosses of the mutant animals to C57BL/6 or BALB/c mice will
clarify this question. In addition, the occasional individuals displaying a single affected eye suggest
that not all variation is due to genetic factors. In contrast to the eye phenotype, the reproductive
failure of mutant females (see below), appears fully penetrant in the 129/Sv inbred genetic
background, suggesting that the suppressor(s) carried by the 129/Sv genome act(s) specifically
during embryonic development.
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A large body of evidence exists for the relevance of activins and inhibins in the biology of
reproduction of both males and females. Initially discovered as antagonistic regulators of FSH
secretion from anterior pituitary cells, activins and inhibins were also shown to exert a variety of local
effects in the gonads, their primary site of expression in adults (see reviews by Vale et al., 1990;
Mather et al., 1992). The decidual tissue, forming in the uterine wall in response to nidation of an
embryo, has also been found to express activin/inhibin 3 subunits. Expression of the PA subunit
mRNA has been demonstrated in the mouse uterine decidua shortly after implantation (Manova et al.,
1992) and PB subunit expression in human decidua was reported to increase in the course of
pregnancy (Petraglia et al., 1990). It seemed possible, therefore, that maternal peptide, secreted by
the decidua, functions in the developing embryo to promote its normal development to birth. We have
thus tested the reproductive capacity of mutant animals. Histological examination of testes and
ovaries from PB deficient animals had failed to detect overt abnormalities. However, when the fertility
of mutant animals mated to heterozygous partners was assayed, it became apparent that mutant
males bred indistinguishably from heterozygous controls, but mutant females suffered an impaired
reproductive performance. While mutant females were able to become pregnant and to carry
pregnancies to the end of gestation, they failed to raise their offspring normally. Perinatal lethality
appeared to affect equally homozygous mutant and heterozygous neonates. This demonstrated that
embryonic development can be completed in the absence of both maternal and fetal PB peptide. The
viability of OB deficient embryos is therefore not dependent upon maternal supply of OB peptide. Our
experiments have, however, revealed a critical role for maternal OB expression in perinatal survival of
the newborns.
The causes that underlie the reproductive failure in mutant females are not resolved. The
newborn pups appeared morphologically normal, suggesting that their death was due to a defect in
the delivery process or in maternal nursing behavior. PB deficient mothers may manifest a defect in
parturition, in postpartum events such as uterine remodeling, lactation, or of the hormonal milieu
affecting maternal behavior. Examination of mammary tissue indicated that lactogenesis was not
impaired in mutant females. The abnormal accumulation of milk in mutant mammary glands suggests,
however, that milk let-down might be impaired. Oxytocin is a hypothalamic nonapeptide which is very
potent in inducing uterine contractions and controlling milk ejection. It is significant that Sawchenko et
al. (1988) have demonstrated P subunit immunoreactivity in the central neural pathways involved in
oxytocin secretion. Furthermore, it was reported that local administration of activin in the
hypothalamus of rats leads to a rapid increase in plasma oxytocin level and infusion of anti-P subunit
serum was reported to inhibit milk ejection (Vale et al., 1990). A local source of oxytocin expression
by the epithelium of the uterine endometrium peaks at parturition (Lefebvre et al., 1992), and is a
potential target of the OB mutation as well. Preliminary analysis of postpartum uteri suggests
morphological alterations in mutant females (A. Vassalli, H. Gardner, unpubl.). It is interesting to note
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that the mutation of another pleiotropic cytokine, leukemia inhibitory factor (LIF), was shown to affect
specifically the reproductive function of females by interfering with the ability of the mutant uterus to
allow implantation of blastocyst embryos (Stewart et al., 1992). Various cytokines may be involved in
the timely regulation of the critical physiological changes which occur in the uterus during pregnancy.
Whether the OB subunit gene is active in pathways of early development that display
redundancy can best be addressed by studying the interaction of the mutated gene with other, early-
acting mutations. For example the presence of the OB mutation may alter the phenotype of embryos
heterozygous or homozygous for mutations that affect mesoderm formation, such as the Brachyury
mutation at the T locus (Lyon and Searle, 1989) or the 413.d mutation in the nodal gene (Zhou et al.,
1993). When mutated in mice, the T gene causes axial deficiencies whose severity are dependent on
the dose of the residual wild-type T function (Mac Murray and Shin, 1988) . Because activin is an
inducer of T, and levels of T expression affect development in a concentration-dependent manner, it
is possible to envisage that activin B deficiency would cause an altered, perhaps enhanced, T mutant
phenotype.
PB deficient mice may also have relevance to the study of tumorigenesis. a subunit mutant
mice (inhibin deficient) develop gonadal tumors early in life with complete penetrance (Matzuk et al.,
1992). In contrast the PB subunit mutant mice do not develop such tumors. Inhibin deficient mice
would be expected to have increased levels of effective activin activity due to the lack of antagonist
activity. The involvement of the OB gene in the mechanisms of tumorigenesis can be studied in a/PB
double mutants.
In summary, the mutations in the jB subunit gene indicate that activins B, AB and inhibin B
are dispensable for embryonic development in the mouse. The gene is, however, active during
prenatal development, as revealed by the failure of eyelid closure in mutant neonates. Secondly
activins B, AB and/or inhibin B function(s) later in adult female life to regulate events that surround
parturition. A deeper understanding of the causes underlying these phenotypes may allow future
study of processes relevant to both development and reproduction.
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Methods
Cloning of the mouse activin/inhibin PB subunit gene and construction of targeting vectors
To clone the mouse OB subunit gene, a 129/Sv mouse strain genomic DNA library derived from the
D3 ES cell line (Doetschman et al., 1985; gift of Drs. En Li and Doug Gray) was screened with a
partial rat OB cDNA fragment (rinB-c2-P, gift of Dr Kelly Mayo, Northwestern University, Evanston,
Illinois). A total of 23 kb of genomic DNA, centered on the OB subunit coding regions, were isolated in
overlapping phages and restriction-mapped. Exons were mapped by Southern blot hybridization with
exon-specific probes (see PCR cloning of mouse PB subunit exon probes). To construct the targeting
vectors, the 17 kb X1 phage insert was cloned into pBluescriptKS- (Stratagene), digested with Narl
enzyme and religated, yielding a construct designated plANarl. This results in the deletion of a 1.3
kb Narl fragment that comprises the mouse coding regions homologous to the coding regions for
amino acids 1 to 137 of the rat precursor chain (Feng et al., 1989b). For positive selection, a PGK-
NEO-p(A) cassette derived from p(KJ1) (gift of Dr Michael Rudnicki; Tybulewicz et al., 1991) and
ligated to Clal linkers, was inserted into the Narl site of p1lANarl. The resulting targeting vector
containing the neo gene in the same transcriptional orientation as the PB subunit gene is termed
pBB1, and pBB2 contains the neo cassette in reverse orientation. Both vectors have the same arms
of homology, of 9.5 kb (5') and 6.0 kb (3').
The 3' breakpoint of the ANarl deletion was confirmed by PCR amplification on tail DNA of a
BB1 allele-specific fragment, "010"/ACT15b, that flanks the breakpoint of the deletion, using a PGK
p(A) primer ("010", 5' AA-CGA-GAT-CAG-CAG-CCT-CTG 3') and an exon 1 OB primer (ACT15b) (see
PCR cloning of mouse OB subunit exon probes). This yielded the expected fragment of 127 bp in
animals carrying a BB1 mutant allele but not in (+/+) littermates. Moreover, the ACT16 primer (5'
ATG-GTC-ACG-GCC-CTG-CGC-AA 3'), which lies within the ANarl deletion, was used in conjunction
with the ACT15b primer to amplify a 138 bp wild-type allele-specific fragment in (+/+) and (+/bbl) but
not in (bbl/bbl) animals, further confirming the 3' breakpoint of the deletion.
PCR cloning of mouse PB subunit exon probes
A mouse exon 1 probe, mACT14/15, and a mouse exon 2 probe, mACT10/11;13, were cloned from
D3 genomic DNA with the use of the Polymerase Chain Reaction. Published rat (Esch et al., 1987;
Feng et al., 1989b) and human (Mason et al., 1989) sequences were used in the choice of primers.
Limited degeneracy was introduced in the primer sequences. For mACT14/15, 700 ng of D3 genomic
DNA was amplified using ACT14 (5' CGA-ATT-CCA-GGA-CAC-CTG-TAC-GTC-GTG 3') and ACT15
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(5' GCG-GAT-CCC-TCT-GCA-AAG-CTG-ATG-AT(CT)-TC 3') primers (0.2 uM each) in a 50 ul PCR
reaction comprised of 10 mM Tris-HCI, pH 9.0 at 25 C, 1.5 mM MgCI2, 50 mM KCI, 0.1% Triton X-
100, 100 ug/ml gelatin, 200 uM dNTPs and 1.5 U Taq polymerase (Cetus). Cycling parameters were
95 C for 1 min., 56 C for 30 sec., and 72 C for 1 min. (5 cycles) followed by 40 cycles of 95 C for 1
min. and 72 C for 2 min. The 318 bp PCR product was gel purified, digested with EcoRI and BamH1,
and cloned into pKS. All 12 clones analyzed were identical and contained the Narl site at the
homologous position to codons for amino acids 137-138 in the rat (Feng et al, 1989b). For
mACT10/11;13, ACT10 (5' CGG-ATC-CGG-C(CT)T-GGA-GTG-(CT)GA-(CT)GG 3') and ACT11
primers (5' CGA-ATT-CCC-ACA-CTC-CTC-CAC-(AGT)AT-CAT 3') (0.5 uM each) were used with the
same reaction components as above, and amplification was carried out by 40 cycles of 94 C for 1
min., 55 C for 1 min., and 72 C for 1 min. The 350 bp PCR products were purified and cloned into
pKS as above. The ACT10 and ACT11 primers amplify both PA and OB gene fragments (see Mitrani
et al., 1990; Thomsen et al., 1990) which are distinguishable by their restriction maps.
Transfection and selection of ES cells
The J1 ES cell line (Li et al., 1992) was established from a male 129/Sv embryo and grown
essentially as described by Robertson (1987). ES cells were cultured on a feeder layer of y-irradiated
embryonic fibroblasts (EF) in Dulbecco's Modified Eagle's Medium supplemented with 15% heat
inactivated fetal bovine serum (Hyclone), non-essential amino acids (Gibco), 10-4 M 0-
mercaptoethanol and antibiotics. Leukemia inhibitory factor (LIF) was added to the medium at 200-
500 U/ml. G418r EFs were prepared from E13.5 embryos carrying a targeted mutation in the 02-
microglobulin gene (Zijlstra et al., 1989).
Two T75 flasks of subconfluent J1 cells at passage 9-10 were trypsinized and resuspended
at 2.5 x 107 ml-1 in PBS. Linearized pBB1 plasmid DNA was added to the cell suspension at a
concentration of 30 ug/ml, and cells were electroporated at 250 V and 250 uF using a BTX 300
electroporator. Electroporated cells were plated on feeder layers of G418 r EF cells at a density of 5 x
106 cells per 9 cm plate. Selection with G418 at 350 ug/ml (dry powder, Gibco) was initiated 20 to 30
hrs later, and carried out for 7-10 days. At that time individual G418 r colonies were picked,
dissociated in trypsin, and plated on wells of feeder-covered 24-well plates. After a 3 to 4-day
expansion, 2/3 of the cells in each well were frozen, and the rest further expanded in the absence of
feeders for DNA preparation.
The pBB2 targeting plasmid was electroporated in similar conditions, but the cells were
resuspended at 5 x 107 ml- 1 in the presence of 25 ug linearized DNA and electroporated in one
cuvette of a Bio-Rad Gene Pulser set at 800 V and 3 uF.
52
Vassalli et al.
Screening of recombinant ES clones and animal genotyping
ES cell and tail genomic DNAs were prepared according to Laird et al. (1991), digested with EcoRI
and submitted to Southern blot analysis, using a 850 bp Bglll-BamHI genomic fragment as a probe (E
in Fig. 1), which lies adjacent 3' to the right arm of the targeting constructs. Of 172 G418r ES clones
transfected with the pBB1 vector, 41 were homologous recombinants, as evidenced by the presence
of a 8.2 kb recombinant EcoRI restriction fragment in addition to the -20 kb wt fragment. Further
characterization of the mutated alleles in 22 targeted clones was done using probe E on BamH1 or
Hindlll genomic digests, and using an internal probe corresponding to the other end of the targeting
vectors (probe A, Fig. 1), as well as a neo probe. Probe A is a 1.5 kb Sall-Bglll fragment
corresponding to the 5' extremity of the left arm of the vectors. These analyses confirmed that 20 of
the 22 clones had undergone the predicted homologous recombination event with no additional event.
The same screening strategy was employed in the pBB2 transfection experiment. Ten ES clones
among 58 that were screened contained the predicted 6.4 kb recombinant EcoRI fragment, indicative
of the reverse orientation of the PGK-NEO-p(A) cassette in this allele. Final washes with both probes
A and E were in 0.2 X SSC, 0.5 % SDS at 65 C.
Blastocyst injections and breeding of chimeras
Embryo manipulations were carried out as described by Bradley (1987). Subconfluent ES cells were
trypsinized, resuspended in injection medium (45% DMEM, 45% Hepes-buffered saline,
supplemented with 10% fetal bovine serum, 10-4 M j3-mercaptoethanol and non-essential amino
acids), and injected into either C57BL/6 or BALB/c blastocyst embryos. Resulting chimeric animals of
both genders were bred to C57BL/6 or BALB/c mates. Both female and male chimeras transmitted
the mutated allele to some of their progeny. To obtain the BB1 mutation in an inbred genetic
background, a chimeric male which had demonstrated high chimerism of the germline was bred to
129/Sv females.
RNA analysis
RNA was isolated from tissue by the Acid Guanidinium Thiocyanate-Phenol-Chloroform extraction
method (Chomczynski and Sacchi, 1987), electrophoresed on a 2.2 M formaldehyde, 1% agarose gel
and transferred onto Zetabind membrane. Blots were hybridized to the mACT10/11;13 probe (see
above) or a neo probe, consisting of a 600 bp Pstl fragment of p(KJ1).
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Protein analysis
Ovaries from individual 3-week old females were homogenized in 50 mM HEPES (pH 7.5), 150 mM
NaCI, 10% glycerol, 1% Triton X-100, 1.5 mM MgCI2, 1 mM EGTA, in the presence of 2 mM PMSF, 5
ug/ml Chymostatin, 5 ug/ml Pepstatin A, 5 ug/ml Leupeptin, and 25 ug/ml Aprotinin. Protease
inhibitors were from Sigma. Extracts were spun and total protein in supernatants was quantitated by
BCA assay (Pierce). Extracts were run in reducing conditions on 15% polyacrylamide-SDS gels and
transferred to nitrocellulose. Equal loading of protein was verified by Ponceau S staining of the
membrane after transfer. All subsequent incubations and washes were done at room temperature.
Blots were blocked with 5% Carnation nonfat dry milk, 0.2% NP-40 in Tris-buffered saline (TBS; 50
mM Tris-HCI (pH 7.4), 150 mM NaCI) for 30 min., and then incubated overnight in primary antibodies
diluted in blocking buffer. After being washed once in 0.2% NP-40 in TBS and twice in 0.1% Tween-
20 in TBS, blots were blocked again, incubated for an hour in anti-rabbit HRP-conjugate antibodies
(Sigma), that had been diluted (1:10,000) in blocking buffer. Blots were then washed as above, rinsed
in TBS, and detected by Enhanced Chemiluminescence (Amersham).
Anti-peptide affinity purified rabbit antibodies were a generous gift of Dr Wylie Vale (Vaughan
et al., 1989). The 3B-specific antibodies were directed against peptide (80-112)-NH2 of the mature OB
subunit and the PA-specific antibodies recognize peptide (81-113)-NH2 of the mature PA subunit.
Both antibody samples were used at a dilution (1:300). The anti-a subunit antibodies were directed
against a human inhibin ao(1-25)-Gly-Tyr peptide and were used at a (1:150) dilution. Specificity was
confirmed using human recombinant activins A and B, and inhibin A as standards run in parallel in
Western blotting assays. Human recombinant proteins were kindly provided by Drs Jennie Mather
and Lynne Krummen (Genentech).
Histological analysis
Neonate mice were fixed in 10 % buffered formalin. Heads were dehydrated, paraffin embedded, and
serially sectioned in the transverse plane. Sections were stained with hematoxylin and eosin.
Abdominal mammary glands were processed similarly and sectioned longitudinally.
FSH measurements
Blood (0.5 ml) was taken by retroocular bleeding of animals that had been ether anesthetized. All
mice used in the study shown in Table 4 were non-breeding animals. Serum was prepared and FSH
values were determined by radioimmunoassay, as described by Matzuk et al. (1992).
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ABSTRACT
Activins are hetero-dimeric (PA:PB) and homo-dimeric (PA:5A; PB:PB) members of the TGF-P
superfamily. 1 The PA and B13 subunits are expressed in multiple embryonic and extraembryonic tissues
during murine development.1- 7 Gain of function and dominant negative loss of function experiments in
Xenopus laevis and Oryzias latipes have suggested a role of activins in mesoderm induction and
neurulation.8-15 To define the in vivo functions of activins in mammals, mice with mutations in activin-3A or
both activin-PA and activin-PB were generated. Activin-PA-deficient mice develop to term, but die within 24
hours of birth. They lack whiskers and lower incisors and have defects in the secondary palate including
cleft palate, demonstrating a role of activin-PA in craniofacial development. Mice lacking both activin-PA
and OB display the defects of both the individual mutants and no additional defects, indicating that there is
no functional redundancy between these proteins in embryogenesis. In contrast to the suggestion from
experiments in lower vertebrates,8-15 zygotic expression of activins is not essential for mesoderm
formation in mice.
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Activins (Figure 1A) demonstrate high conservation during vertebrate evolution.1 , 8-10, 16-18
Components of the activin signal transduction cascade are expressed during embryonic development in
fish, amphibians, birds, and mammals. 1-10, 14, 15, 17, 19-21 In the mouse, activin-PA and OB subunits
are expressed zygotically prior to implantation,23 but only in the maternal deciduum3 , 6, 7 until E10.5
when activin-PA begins to be expressed in mesenchymal cells of the developing face, whiskers, hair
follicles, heart, and digestive tract.7 , 20, 21 This broad spectrum of expression and the extreme
evolutionary conservation suggest that activins play a key role in mammalian development.
Mice deficient in activin-PB have been reported previously.22 They are viable but exhibit a defect
in eyelid development and impaired female reproduction but no apparent mesoderm defects.22 To
further address the functional roles of activins in mammalian development, mice with a disrupted activin-PA
allele were generated using embryonic stem cell technology. Heterozygous (actPAml/+) mice were fertile
and viable and were intercrossed to obtain actPAml/actPAml mice (activin-PA-deficient). Genotype
analysis of the progeny from these intercrosses (Figure 1C) revealed normal Mendelian ratios with 25.1%
wild-type (68/271), 49.4% heterozygotes (134/271) and 25.5% homozygotes (69/271) indicating that
actpAm l/actfAm I mice survived to birth. The activin-PA-deficient mice (Figure 2A) appeared healthy at
birth, they breathed normally, and were similar in weight to controls [actPAml/actpAml, 1.19_0.12g
(n=22); littermate controls, 1.24_0.11 g (n=23)]. Although actPAml/actpAml mice progressed to term at
the expected frequency, they died within 24 hours of birth. The actPAml/actfAml mice lacked whiskers
and incisors (Figure 2B-D), consistent with the expression of activin-PA mRNA in the mesenchyme of the
whisker follicle and teeth primordia. 7 , 20, 21 Analysis of skeletal preparations demonstrate the absence of
lower incisors (complete absence in 22/25 mice) compared to controls (Figure 2B). Immature tooth buds
could be detected in histological sections (Figure 3). Histologic analysis of the whisker-pads demonstrate
an apparent delay in growth and/or differentiation of the whisker follicles (Figure 2E,F). Unlike control
littermate mice, the root sheath, if present, appears immature, the cells at the base of the hair bulb often
form an irregular pattern, and the hair papilla always lies closer to the surface (Figure 2F). Thus, activin A is
required for the normal development of whiskers and teeth (incisors).
actfAml/actpAml newborn mice, identified by the lack of whiskers, failed to suckle. Gross
anatomical observations revealed that these mice had a cleft palate which is a major cause of the feeding
problems. 12 of 42 (29%) hybrid background (C57BI/6/129SvEv) and 3 of 9 (33%) 129SvEv inbred
actfAml/actIPAml newborn mice demonstrated cleft secondary palate (Figure 3). Skeletal preparations of
22 actfAml/actPAml newborn mice (hybrid background) which did not have clefts of the secondary
palate revealed that 7 of 22 (32%) lacked a hard palate whereas the majority of the remaining mice
exhibited incomplete development of the hard palate (Figure 3).
To generate mice deficient in all activins and therefore lacking both activin- PA and activin-PB
subunits (Figure 1A), actlPAml/+ mice were interbred with actPfBml/+ mice22 to generate compound
heterozygous mutant mice (actpAml, actPBml/+, +). Compound heterozygous mutant mice were
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interbred and compound homozygous mutant mice (actPAml, actPBml/actpAml, actpBml) deficient in all
activins and inhibins were viable at birth (Figure 3F) and seen at the expected frequency (Table 1).
actfAml , actpBml/actpAml, actPBml mice were readily identified since they exhibit phenotypic
characteristics of the single mutant lines. These mice lacked whiskers and had eyelid defects (i.e., open
eyes; Figure 3F), and appear to have died of palate defects with 3 out of 9 (33%) having cleft secondary
palate. Furthermore, the actPAml, actPBml/actfAml, actPBml mice were comparable in weight (1.08 _
0.11 g; n = 9) to their littermates (1.08 _ 0.13 g; n = 35) and did not appear to have any additional defects
that were not observed in the individual activin-PA or PB mutant mice.
The absence of whiskers and incisors and the defects in the formation of the secondary palate in
the activin-PA-deficient mice are consistent with the expression of activin-PA mRNA,7 , 19, 20 and the in
vitro effects of activin on chondrogenesis and bone formation.23 , 24 The cleft palate and mandible and
incisor defects are similar to the defects seen in Msxl-deficient mice.25 The incomplete penetrance of
the "cleft" is reminiscent of human cleft palate and the multifactorial nature of its development.26
Interestingly, mice with the recessive mutation, oel, had cleft palate, open eyelids, and died perinatally 27
similar to the compound homozygous activin-PA/PB mutant mice. The phenotype in the oel mice is
consistent with a defect in a common downstream component of both the activin A and B signal
transduction cascades. The observation that activin NA/PB double mutant mice have a phenotype which is
an additive combination of the single mutant phenotypes indicates that the individual activin homodimers
are not functionally compensating for one another during development and that the activin-pA:pB
heterodimer does not appear to have a unique function during embryogenesis.
Although we have shown that zygotic activins are not essential for mesoderm induction in mice, a
recent study with TGF-P1 mutant mice suggests that maternal TGF-P1 may cross the placenta to partially
rescue the mutant mice. 28 Since activin-PB-deficient mice demonstrate normal mesoderm-derived tissue
when delivered from activin-PB-deficient mothers,21 clearly the maternal or decidual activin B is not
essential. Similar studies with activin-PA-deficient females cannot be performed. The overexpression of
activin subunits, receptors, and truncated receptors in Xenopus laevis and fish might influence mesoderm
induction8-15 because of interactions with other TGF-P family members29-31 and their receptors. For
example, a truncated Xenopus activin receptor type II has been shown to block the activity of Vgl, a
related TGF-P family member.29 Identification of the serine/threonine kinase receptors expressed around
the time of mesoderm induction will give us a better understanding of the TGF-P-related proteins involved
in this process. Lastly, mutant mice deficient in one of the activin receptors, activin receptor type II
(ActRcll), (accompanying manuscript) do not overlap phenotypically with the activin-PA/PB compound
mutants. This raises the question about the relevance of ActRcll, as a receptor for activin A and/or activin B
during embryogenesis. Alternatively, the other type II activin receptor, activin receptor type ilB, might be
the major receptor during embryogenesis. The final conclusion on specificity of the ligand/receptor
interactions must come from analysis of ActRcllB mutant mice and the demonstration of epistasis in
compound mutant ligand/receptor mice.
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Figure 1.
METHODS.
63
Structures of activins and inhibins, targeting of the activin-PA gene in ES cells, and
generation of activin-PA-deficient mice. a, The dimeric forms of activins and inhibins.
Absence of PA and 1B subunits abolishes all activin and inhibin activity. b, The targeting
vector to delete exon 2 (1.8 kb of sequence) of the activin-PA gene is shown. The mouse
activin-PA gene is a two exon gene with an 8.8 kb intron. Exon 1 encodes the signal
peptide sequence and 101 amino acids of the propeptide, and exon 2 encodes 181
amino acids of the propeptide and the 116 amino acid mature activin-PA peptide.
Homologous recombination between this targeting vector and the endogenous mouse
activin-PA locus deletes exon 2. The presence of a 4.0 kb fragment using a 5' probe or a
12.3 kb fragment using a 3' probe versus a 14.5 kb wild-type fragment upon restriction
with BamHI is diagnostic of the mutant allele. c, Southern blot analysis of DNA from
offspring derived from heterozygous matings. Genomic DNA (-5 ug), isolated from the
tails of offspring from one litter, was digested with BamH1 and analyzed as described
using a 5' probe. The presence of a single 4.0 kb fragment in the four lanes at the left
indicates a homozygous mutant (-/-) genotype. The four homozygotes at the left did not
have milk in their stomachs and lacked whiskers.
21.6 kb of isogenic DNA sequence encompassing the 2 exon mouse activin-PA gene
was isolated from a mouse 129SvEv library. Linearized vector (25 ug) was electroporated
into the hprt-negative AB2.1 ES cell line, selected in HAT and FIAU, analyzed by
Southern blot analysis, and injected into chimeras as described.32 , 33 Enrichment in
HAT and FIAU was 14.4-fold compared to HAT alone. Southern blot analysis of ES cell
DNA identified 14 targeted clones out of 115 clones screened. The mutant allele was
transmitted from chimeras derived from independent clones PA5-F12 and PA6-D5. To
confirm the nature of the mutant allele, a cDNA probe encoding the activin-PA C-terminal
(mature) sequence was hybridized to DNA from the actPAml/actpAml mice. The lack of
hybridization to a wild-type activin-PA allele confirmed that the mutant actPAml allele was
null (data not shown).
Activin A
ps OE
Activin B Activin AB
n A Inhibin B
Figure 1A
Inhibi:
a ~PB
PB..
C(
c
0 L LC cd
0>
S0x O0 oz
r; 0E
0 a E
E
t"
C/)r
E
0
0no
cc
(I-
cn
O-
zo(D
.0
[LM
LL
L.
..
(D0-CD
LO
WI
c0
.0C\11
F .
0
E
I
Efm .
coO
c-
m
E•
5
I,0
X
c,
c"
z0 C
x w..
m
e-
M
m
CI
.-C
Q.
I
r
B
·i·
rl
i:EE m - *
m
Irr
m E
~IM
-/4
_I1o
,0
l0
c,
0
*
0
Cl)
r
I
-.1
co
I~
ed
PD
Matzuk et al.
Figure 2. Morphologic and histologic analysis of activin-PA mutant and control mice. a, wild-type
(left) and activin-PA-deficient homozygote (right) newborn littermate mice. Note the
absence of milk in the stomach of the activin-PA-deficient mouse compared to the wild-
type control (arrow). b, medial view of wild-type (top) and actPAml/actpAml (bottom)
dissected mandibles stained with alizarin red and alcian blue. The alveolar ridge (A) is less
prominent and the incisor (I) is missing in the mutant. c,d, gross analysis of the whisker
pads and face of a wild-type control (c) and actPAml/actpAml (d) newborn mice
demonstrating absence of whiskers in the mutant (d) mouse. e,f, histologic analysis
(hematoxylin and eosin stain as described)33 of the whisker follicles of control (e) and
actPAml/actpAml (f) mice. Photographs e,f, were taken at the same magnification.
Transverse sections through the whisker pads were performed. Note that the distances
of the hair papillae (P) from the surface in the mutant (f) are shortened compared to the
control (e). In addition, the hair bulbs (B) in the mutants (f) are less well-formed than in the
control (e). The root sheath (S) is obvious as it approaches the epidermis in the control
(e), but is rarely visible in multiple sections examined for mutants.
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Figure 3:
METHODS:
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Histologic analysis of the palate and surrounding tissues (a-e) and morphologic analysis of
compound homozygote mice (f). Coronal sections at the level of the eye of wild-type (a, b)
and actfAml/actpAml (c-e) mice. Note the normal joining of the lateral palatine processes
to form the hard and soft palate in the wild-type mouse (arrow) photographed at low (a)
and high (b) magnification. The hard palate (arrow) has not formed in the mutant
photographed at low (c) and high (d) magnification which is evident by a lack of bone
matrix and a "sagging" of the palate. There is a cleft palate (CP; absence of both hard and
soft palates) in another mutant (e). f, newborn control (left) and compound homozygote
actPAml, actfBml/actpAml, actfBml (right) mice. Both mice were living at the time of the
photograph. The mutant mouse (right) had open eyes and lacked whiskers and was
approximately the same size and weight as the control.
Coronal sections through the palates were processed as described32 and stained with
alcian blue and neutral red. Southern blot analysis of DNA from newborn offspring born
from intercrossing of compound heterozygous activin-PA/PB mutant mice was as
described.22 , 23 Southern blot analysis to determine the activin-PA genotype utilized the
5' probe described above and analysis of the activin-PB genotype utilized a 3' probe as
described.22 Tail DNA was digested with BamH1.
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Table 1. Genotype analysis of offspring generated from compound heterozygous mice.
A B Number Obs. % Exp. %
WT* WT 10 8.0 6.25
WT +/- 13 10.4 12.5
WT -/- 10 8.0 6.25
+/- WT 11 8.8 12.5
+/- +/- 34 27.2 25
+/- -/- 16 12.8 12.5
-/- WT 4 3.2 6.25
-/- +/- 13 10.4 12.5
-/- -/- 14 11.2 6.25
TOTAL 125 100.0 100.0
*WT, wild-type; +/-, heterozygote; -/-, homozygote.
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PART 1 : DISCUSSION:
I will now briefly summarize the phenotype of the activin / inhibin flB deficient mice and the
conclusions we can draw from it. Surprisingly, these mice did not show an overt mesodermal
defect, or other early developmental failure. They are viable and suffer from eye defects and
female reproductive dysfunction.
The limitations of single gene knockouts when they do not yield the expected phenotype
will be discussed. Lack of a scorable phenotype may stem from the existence of overlapping,
"redundant" pathways in development, to the activation of compensatory by-pass events that do
not normally occur, or altogether from irrelevancy of the particular gene in the function studied.
Further studies aimed at distinguishing these possibilities will be proposed.
1.8 The phenotype of activin / inhibin B deficiency: i. Viability
Upon intercrossing animals heterozygous for the OB subunit mutation, we obtained a frequency
of 21% (n=223) (in the 129/Sv X C57BL/6 background), or 17% (n=158) (in the 129/Sv X BALB/c
background) of weanling mice homozygous for the mutation, instead of the Mendelian
expectation of 25%. Thus activin / inhibin B deficiency is not a lethal condition and may only be
marginally deleterious to embryonic development. The generation of viable mice provided the
definitive evidence that the single mutation in the OB subunit gene does not prevent mesoderm
formation in mouse embryos. We cannot however conclude on the normality of early inductive
events in OB deficient embryos, as embryos themselves have not been analyzed yet. Such an
analysis may reveal alterations in morphogenetic pathways (see below). Our data, however,
establish the dispensability in mice of activins AB, B, as well as inhibin B, for the generation of a
normal body plan.
It is very difficult to speculate on the significance of this result with regard to other
vertebrate species. A vast amount of literature exists on the roles of activins on mesoderm
formation in frog and chick embryos. In addition to the data demonstrating expression in embryos
and responsiveness of embryonic explants to activin A or B, there also is functional evidence for
such a role. Interference with the activin pathway in Xenopus embryos by injection of a synthetic
mRNA encoding a truncated activin receptor prevents mesoderm induction and axial structure
formation (Hemmati-Brivanlou and Melton, 1992). As a control of the specificity of this effect,
responsiveness to FGF is preserved in injected embryos. It nevertheless remains possible that
the truncated activin receptor interferes in this experiment with signaling by TGFP-like molecules
other than activin. This caveat aside, the data point to the existence of an essential activin
signaling pathway in Xenopus embryos. At this point of analysis, considering the lack of
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mesodermal phenotype in activin B deficient mice, it would appear that either frog and mouse
development differ in the roles played by activin B, or that a different factor (possibly activin A, see
below) is able to participate in mesoderm formation in both species.
Despite the lack of an overt early defect, the 3B mutant mice were found to suffer from
distinct later developmental and reproductive defects and alterations which are described below.
ii Failure of eyelid fusion
PB mutant mice manifested a distinctive phenotype at birth. During late embryogenesis,
mesenchymal cells of the eyelids normally proliferate to undergo apposition and eventual fusion
of the eyelids at embryonic day 16 (E16). Mice are thus normally born with closed eyelids, and
eyes re-open at -13 days of postnatal life. In contrast, many PB deficient mice were born with
open eyes, and quickly developed a series of secondary eye lesions.
It is intriguing to note that many apparently unrelated mutations similarly cause birth with
open eyes in mice. This had suggested that the open eyelid phenotype may not be specific, but
indicative of subtle morphogenetic alterations occurring in the context of a variety of genetic
defects. For example, the process of eyelid outgrowth and fusion may be especially sensitive to
sublethal developmental perturbations, such as found in c-abl and TGFa deficient mice, as well as
in a variety of lines carrying mutations that have not yet been identified, all of which get born with
open eyes (Lyon and Searle, 1989; Schwartzberg et al., 1991; Luetteke et al., 1993; Mann et al.,
1993).
However, expression of the activin PB mRNA was recently demonstrated in a variety of
specific locations in the postimplantation mouse embryo (Feinjen et al., in preparation), and this
suggested a more specific role of activin B in the developing eye. Condensations of
mesenchymal cells in the tarsus of the developing eye, which is precursor of the eyelid, were
found to highly express PB mRNA at E12.5 of development. Activin B may thus act as an
important, surprisingly specific, growth factor for these cells.
The eyelid fusion phenotype was found to depend on the genetic background of the
mice. It was observed in the two hybrid genetic backgrounds tested (129/Sv X C57BL/6 and
129/Sv X BALB/c) (with incomplete penetrance), but was never observed in the 129/Sv inbred
background. After four generations of backcross to C57BL/6, the eyelid fusion defect displays
complete penetrance in mutant newborns. This suggests that the 129/Sv genome contains an
allele(s) that acts as a suppressor of this phenotype.
In contrast to the eyelid defect, the other overt phenotype of the PB mutation (see next
section) was fully penetrant in all three genetic backgrounds, suggesting that the 129/Sv
suppressor acts specifically during embryonic development.
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iii Female reproductive dysfunction:
As secreted factors, activins and inhibins potentially gain access to the developing embryo from
maternal sources during gestation. Decidual or placental activins, for example, may participate in
normal development of the embryo, and may rescue the zygotic null genotype. Additionally, as
was mentioned earlier, the mouse oocyte contains both RNA and protein for activin. Thus
initiation of development occurs in the presence of maternal activin. For these reasons, to fully
address the question of the roles of activins during mouse embryogenesis, development must be
assessed in the context of a maternal deficiency as well. This was made posssible by the fact that
OB deficient females are viable, and they were thus tested for their ability to produce live offspring.
Furthermore, among the pleiotropic functions attributed to activins and inhibins are
various activities in reproduction itself (for reviews, see Vale et al., 1990; Mather et al., 1992), thus
prompting us to assess reproductive performances in both sexes. In adult animals, activins and
inhibins are mainly produced by the gonads, and are thought to be important regulators of
reproductive functions through their influence on both the pituitary and the gonads. In addition to
their regulatory effects on FSH release from the anterior pituitary, intragonadal autocrine and
paracrine activities on both somatic and germ cells have been described. For example, activins
and inhibins were reported to affect spermatogonial proliferation in the male and follicular
development in the female (Vale et al., 1990; Mather et al., 1992). When reproductive
performances of mutant animals were assessed, mutant males were found to breed normally. On
the other hand, mutant females showed a profoundly impaired reproductive ability.
Most OB deficient females generated few, if any, viable progeny in their lifetime. The
impairment was found not to be caused by a defective oogenesis, or an unability to sustain
gestation. Mutant females were found to be able to give birth to live, morphologically normal
neonates including homozygous mutants, thus disproving the hypothesis that maternal activins
rescue the 3B mutant animals in utero. Rather, the poor fecundity of mutant females resulted from
a maternal defect leading to perinatal lethality of the offspring. The nature of this defect is
incompletely resolved. It may lie at multiple levels of pre- and postpartum female physiology, as
suggested by the three following observations:
(1) Even though mutant females often failed to nurse their offspring, lactogenic lobular
development was seen in mutant mammary tissue. Excess milk accumulation was observed in
mutant ducts and lobules. This suggested a defect in milk let-down. In this context, it is significant
that activins have been implicated in regulation of hypothalamic oxytocin secretion (Vale et al.,
1990). Oxytocin is a nonapeptide implicated in milk ejection and uterine contractions.
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(2) Postpartum histological analysis of mammary glandular and uterine endometrial tissue
suggested hyperplasia of both epithelia (unpublished observations).
(3) Timed mating experiments have shown that mutant females have a prolonged gestation.
Normal delivery occurred on day E19.5 of gestation (in 12/13 control females). In contrast, very
few PB deficient females (1/13) had delivered on that day (Table IV, page 82). Mutant females
delivered on day E20.5 or E21.5. Furthermore, they were occasionally found to experience a
failure in the delivery process, resulting in death of the offspring in utero.
In summary, maternal 3B expression was found to be dispensable for embryonic
development of the offspring, as mutant females were able to give birth to live babies, but was
found to be critical for their perinatal survival.
1.9 Limitations of single gene knockouts
and strategies to overcome them
As the activin B mice illustrate, knowledge of the expression pattem of a gene and of the in vitro
activity of its product are not sufficient for a prediction of its loss-of-function phenotype.
Disruptions in, for example, the c-src, MyoD, or TGFa genes have also produced mice with a
considerably milder phenotype than expected (Soriano et al., 1991; Rudnicki et al., 1992;
Luetteke et al., 1993; Mann et al., 1993). c-src deficient mice develop apparently normally, but
suffer osteopetrosis later in life. TGFX mutant mice are viable, but with wavy hair and whiskers, and
mice lacking MyoD are viable and fertile.
When inactivation of a candidate effector in a particular process fails to reveal abnormality
in this process, it is desirable to know whether this results from compensation by other genes
(redundancy or use of a 'by-pass', alternate pathway), or rather because the gene in question
simply does not participate in the process. Here I will describe three ways to address this question,
and how they apply to the activin OB subunit mutant mice.
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i . Spatial and temporal analysis of development
The disruption of a gene that acts during embryogenesis may not arrest development, but
nevertheless alter its course. This may not be readily apparent in the adult mutant animal.
OB mutant embryos have not been analyzed. Morphological analysis and expression
studies of the known activin response genes, and of other genes thought to participate in early
inductive events, may indicate whether development is spatially or temporally altered. A delay in
onset of expression of mesodermal genes, such as Brachyury, Evxl, goosecoid or Sna would
indicate that activin B is involved in elaboration of mesoderm, but that compensatory pathways
exist or are activated in 3B deficient embryos. Such an analysis was very informative in the case of
the Myf-5 gene (Braun et al., 1992). Myf-5 is temporally the first of a series of four myogenic Helix-
Loop-Helix (HLH) transcription factor genes to be expressed in mouse embryos and transfection
of a Myf-5 expression vector into a variety of cell lines converts them into muscle types. Most
surprisingly, Myf-5 deficient mice develop normal muscle. When embryos were analyzed at stages
of myotomal differentiation however, activation of expression of several muscle markers was
delayed by several days. Therefore the Myf-5 gene belongs to a pathway of muscle differentiation
that displays redundancy.
ii . Analysis of expression of related genes
Genes of the same multigene family as the mutated gene may be altered in their expression in the
mutant animal.
Inactivation in mice of the gene that encodes the myogenic HLH transcription factor MyoD
did not result in an overt phenotype. Remarkably, apparently normal muscle development occurs
in mice lacking MyoD (Rudnicki et al., 1992). Molecular analysis revealed that mutant animals up-
regulate the expression of the related HLH gene Myf-5. The latter gene itself is not essential for
muscle development , as Myf-5 deficient mice, although lacking normal ribs, develop normal
muscle (Braun et al., 1992). The role played by Myf-5 is however essential in the MyoD mutant to
achieve normal muscle development, as the MyoD / Myf-5 compound homozygous mutant lacks
skeletal muscle altogether (Rudnicki et al., 1993) (see below).
Expression of the two other activin / inhibin subunits (a and PA) in PB mutant immature
ovary (3-week) was examined both at the protein and RNA levels. It was found that whereas
inhibin a subunit levels were unaltered in OB mutant tissue, the related PA subunit was highly up-
regulated (3- to 20-fold). This up-regulation is not accompanied by similar alterations at the RNA
76
Part 1 Discussion
level. It is therefore achieved by a post-transcriptional mechanism. Regulation may be
translational, or may be at the level of peptide stability.
The finding of up-regulation of PA subunit in the PB deficient ovary opens the possibility
that similar regulatory mechanisms operate in the embryo, and provide a means for normal
morphogenesis in absence of activin B. Addressing this question requires the generation of a
true activin-less embryo by inactivation of the PA subunit gene and intercross of both mutants
(see below).
iii . 'Double KOs'
The full potential of the ES cell gene targeting technology becomes realized when individual
single mutants are intercrossed, and multiple genetic interactions are studied in the context of the
developing animal.
In one of the first genetic analyses of redundancy in the mouse, the individual roles of
non-receptor src-like Tyrosine protein kinases, and the level of their mutual functional overlap, are
being studied in single and compound targeted mutant lines (Soriano et al., 1991; Stein et al.,
1992; Grant et al., 1992; Lowell et al., 1994). As an example, hck-/- ; fgr -/- mutant mice displayed
an increased susceptibility to infection with Listeria monocytogenes, an intracellular bacterium, a
phenotype not observed in either single mutant (Lowell et al., 1994). Therefore, either hck or fgr
is required to maintain natural immunity in mice.
A genetic analysis of the family of insulin-like growth factors (IGFs) and their receptors,
using targeted mutants in the IGF1, IGF2 and IGF1R genes, has revealed interactions between
these genes, showing increasingly severe deficiency in body growth and viability in some of the
compound mutants (Baker et al., 1993; Liu et al., 1993). In addition, a spontaneous deletion
exists that encompasses the IGF2R gene, T-hairpin (Thp). This mutation shows a mid-gestation
dominant lethal effect when transmitted by the mother, due to imprinting of the IGF2R gene,
expressed solely from the maternal allele. Interestingly, a rescue of the ThP lethal maternal effect
was achieved by crossing Thp/+ females with IGF2-/- males and generating mice lacking both IGF2
and IGF2R expression (Filson et al., 1993). This suggested that the maternal lethal effect of the
Thp mutation is in fact due to defective clearance, and consequent excess of IGF2 in embryos
that lack the IGF2R.
One of the most striking demonstrations of functional overlap within a gene family was
provided by the MyoD / Myf-5 mutant mice (Rudnicki et al., 1993). As mentioned earlier, MyoD
mutant mice have no overt phenotype, whereas Myf-5 mutants die perinatally because of
defective thoracic cage formation. In the double mutant, however, there is a complete block in
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skeletal muscle formation. Therefore, these genes can substitute for one another in skeletal
muscle formation.
More subtle effects of gene dosage can be observed. Thus, whereas the lack of MyoD
has no apparent muscle phenotype, combined with heterozygosity at the Myf-5 locus (in MyoD -/-;
Myf-5 +/- animals), it leads to a lethal muscle insufficiency (Rudnicki et al., 1993). Therefore a
recessive mutation (Myf-5) can show co-dominance if associated with a second mutation. As
(MyoD +/-; Myf-5 -/- ) animals have normal muscle, this also shows that, although the two genes
possess overlapping functions in myogenesis, they differ in their dose-effect relations: one allele
of MyoD appears sufficient to complete myogenesis, but one allele of Myf-5 does not.
In an attempt to determine whether activin B participates in early development, we have
intercrossed the OB mutant with Brachyury heterozygous mice (T/+). The T mutation leads to a
semidominant phenotype of tail-shortedness in heterozygotes, whereas homozygosity is lethal in
mid-gestation. T/T mutants manifest a defect in migration of nascent mesoderm and a deficient
notochord (see Beddington et al., 1992). It has been shown that the phenotype of various mouse
T mutants is T dose-dependent, in that a graded severity in deficiency of posterior body
development is observed as wild-type T function is diminished (Mac Murray and Shin, 1988). As
inducers of T expression (Smith et al., 1991), activins may contribute to normal T levels. Thus an
activin B homozygous deficient condition may further reduce T dose in T/+ heterozygotes, and
potentially aggravate their phenotype, leading to further truncations in the posterior body, such as
spina bifida. In T/T homozygotes, activin B deficiency might also increase the severity of the
phenotype.
Upon intercrossing compound heterozygous animals, we have obtained a normal
frequency of OB -/-; T +/- animals. These mice displayed eye defects and short tail, with no overt
additional defect, indicating that at the heterozygous level, the T mutant phenotype was not
aggravated by the lack of activin B. Although PB -/-; T -/- embryos were not analyzed, these
preliminary data do not suggest a genetic interaction between the two mutations.
Activins A, AB, and B are thought to have identical activities, although different
expression patterns. Matzuk et al. (in press) have generated mice carrying a deletion in exon 2 of
the gene encoding activin / inhibin PA subunit. Homozygotes, deficient in activins A, AB and
inhibin A, can be recognized at birth by their lack of whiskers. They also suffer defects in
secondary palate formation, including sometimes cleft palate, and die shortly after birth from
inability to feed. In order to create a mouse deficient in all activins, we have intercrossed the OB
and the PA mutants. In compound heterozygote matings (PA -/+; OB -/+) X (OA -/+; 3B -/+), all
classes of progeny were recovered at birth in Mendelian frequencies. A fraction of the offspring
displayed both defective eyelid fusion and absence of whiskers and died shortly after birth. These
animals represented the compound homozygotes (PA -/-; 3B -/-), deficient in all activins and all
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inhibins. Thus, the compound mutant phenotype appeared no more severe than the sum of the
individual phenotypes, indicating that no apparent functional overlap exists between the OA and
OB genes. It can therefore be concluded that embryonic activins are dispensable for early mouse
development. This is in contrast to the evidence in amphibians which points to an essential role of
activins in mesoderm induction and axial structure formation (Hemmati-Brivanlou and Melton,
1992).
One caveat of the mouse experiments is that we cannot assess the importance for
embryonic development of the expression of the PA subunit gene in the uterine decidua of the
mother, since PA deficient females invariably die shortly after birth. The importance of maternal
effects is described in the next section.
1.10 The importance of maternal effects
In Drosophila, genes that affect early development are of two fundamental classes, maternal or
zygotic. Similarly in Xenopus, early development is governed by maternal determinants, stored in
the egg in form of mRNAs or proteins. At the midblastula transition, zygotic gene expression takes
over control of further development. In contrast, mouse embryos are already active in transcription
at the late 1-cell stage, and are thus largely controlled by their own genes. Therefore, the genetics
of early embryogenesis in mice are usually adequately addressed by performing intercrosses
between parents heterozygous for the mutation of interest. However, in two sets of cases,
heterozygote intercrosses are not adequate to determine the phenotype of a true 'protein
knockout' in the embryo. These are the cases when the heterozygous mother contributes the
wild-type gene product during development:
1) The female gamete itself can contribute wild-type RNA and/or protein to the early developing
embryo. This is plausible in the case of activins, because mouse oocytes contain RNA and protein
for both PA and 3B subunits (Albano et al., 1993). In the fish Oryzias latipes, maternally provided
activin, in contrast to zygotically expressed activin, was recently shown to be essential for
mesoderm and axis formation (Wittbrodt and Rosa, 1994).
2) In all mutations that affect extracellular, secreted gene products, transfer of the wild-type
protein potentially occurs from maternal sources during development and rescues the embryo.
The maternal protein may be expressed by the uterine decidua, the placenta, or gain access to
the embryo via the blood circulation.
For example, TGFi1 mutant mice undergo apparently normal development in utero, but
die shortly after weaning from a multi-focal inflammatory syndrome (Shull et al., 1992; Kulkarni et
al., 1993). Considering TGF~1 expression and postulated functions, it was a surprise that these
mice lack an embryonic phenotype. Recently, it was shown that iodinated TGFi1 administered
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intracardially to the mother transfers efficiently to the fetus (Letterio et al., 1994). In addition,
several tissues of TGFl1 -/- neonates born from heterozygous mothers were found to
immunostain for TGFi1. In this study a single TGFl1 -/- female was rescued to breeding age by
daily injections of dexamethasone. Her four homozygous pups displayed severe cardiac
abnormalities and died within one day, whereas three heterozygous littermates appeared normal.
These data suggested that maternal transfer of TGFP1 rescues the TGF31 -/- progeny to weaning
age.
As mentioned above, these limitations in phenotype analysis apply to the activin P
mutants as well. Initially, the oocyte contributes both activins to the early embryo (Albano et al.,
1993). After implantation, both PA and PB subunits are strongly expressed in the maternal uterine
decidua (Manova et al., 1992; Albano et al., 1994). In the case of the PB subunit, the viability of
mutant females allowed to demonstrate that lack of both maternal and fetal PB subunit was
compatible with normal development. In contrast, because PA mutant animals die at birth, the
fertility of mutant females cannot be tested. It remains possible that an essential determinant of
early development is supplied maternally in mammalian embryos, as activin A.
1.11 Constitutive KO vs inducible KO
It is important to reflect on the notion that inactivation of a gene throughout development
("constitutive knock-out") may give a distorted picture of the process we seek to understand. In
the context of a constitutive gene inactivation, the developing organism may develop alternate,
compensatory pathways, that do not prevail during normal development. These changes in
developmental pathways may not be apparent in the final phenotype (e.g. a healthy mouse). On
the other hand, a gene ablation that occurs only at the develomental stage of interest ("inducible
or conditional knock-out") may give different answers. An inducible gene disruption is a better
strategy to investigate the participation of the gene in a specific process. This is especially
important for genes that are active, as activins, at several times of ontogeny. In the case of genes
that are active both during development and adulthood, this strategy is necessary to investigate
the adult function of the gene. For example, contrary to what in vitro evidence could have
predicted, activin / inhibin PB deficient female mice undergo normal oogenesis. In the immature
OB deficient ovary, however, expression of the other activin / inhibin PA subunit is highly
upregulated. It is possible that this upregulation is critical to the development of a functional ovary,
and that a gene inactivation specific to adult stages would lead to female sterility.
A variety of techniques are being tested to generate conditionally inactivated alleles,
using conditionally-expressed site-directed recombinases to catalyze the gene inactivation
reaction in a cell- or developmental stage-specific manner.
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1.12 The real mesoderm inducer?
If not activins, what are the real inducers ? The gene mutated by the 413.d retroviral
integration encodes an essential, non cell-autonomous function in mesoderm formation (Conlon
et al., 1991), which when cloned proved to be a TGF3 family member (nodal; Zhou et al., 1993). Its
expression in the mouse node is consistent with it being a direct player in the events that
surround gastrulation. It will be very interesting to see whether nodal protein has mesoderm
inducing activity and whether it is capable, as activins are, of inducing early-acting genes such as
Brachyury and goosecoid. Another mutation has been shown to affect specifically mesoderm
induction in mouse embryos, the msd mutation (mesoderm defective; Holdener et al., 1994). This
mutation, contrary to the 413.d mutation, is cell-autonomous. Although primitive streak formation
is blocked in both mutants, their phenotype differ markedly. The msd mutation has the features of
a mutation that would affect the receptor or other downstream effector of a mesoderm inducing
signal. The molecular cloning of the genes affected in such mutants, in combination with the
targeting of known genes, will initiate a genetic understanding of mesoderm induction, and allow
tests of epistasis. By comparison with the genetics of the zebrafish, for instance, it will be possible
to appreciate to what extent these genetic pathways have been conserved throughout vertebrate
species.
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APPENDIX 2 :
RANDOM INSERTIONAL MUTAGENESIS:
THE MOV34 EMBRYONIC LETHAL
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ABSTRACT
Retroviruses can be used to create novel, random insertional mouse mutants. The retrovirus
serves both as the mutagen and as a molecular tag to allow efficient cloning of the affected locus.
A total of 66 mouse strains carrying single retroviral insertions were previously generated. When
bred to homozygosity, 4 of them displayed an overt mutant phenotype. The Mov34 strain carries
an early embryonic lethal mutation. While Mov34/Mov34 mutant embryos develop apparently
normally up to the blastocyst stage, they arrest shortly after implantation, at day - E4.5-E5.5.
Molecular cloning and analysis of the disrupted locus had identified a novel gene, termed Mov34,
highly conserved among species including Drosophila, but with no known function. An unusual
feature of the protein sequence was the presence of a highly charged C-terminal tail consisting of
alternating positive and negative charges. Expression of the Mov34 1.7 kb transcript appeared
almost ubiquitous in mouse tissues, suggesting that this gene may serve a general, "house-
keeping" function. In this context, the question of the survival of the homozygous mutant
embryos until implantation is of particular interest. In contrast to other vertebrates, early
development in mammals is controlled primarily by embryonic gene expression, rather than by
maternal determinants. We have been interested in assessing the causes that underlie the
lethality of this mutant at the time of implantation . Here we show that the Mov34 transcript is
maternally encoded in the primary oocyte, remains present throughout continuation of meiosis,
and is degraded in the one-cell embryo. During later preimplantation development, the transcript
reappears at the 4-cell stage and becomes prominent by the blastocyst stage, behaving as a
constitutively expressed mRNA. Therefore, the expression pattern of the 1.7 kb transcript is
consistent with its deficiency causing the Mov34 phenotype. This expression pattern may further
indicate that maternal transcript provides sufficient Mov34 protein for survival until implantation.
We have generated anti-peptide antibodies directed against Mov34 sequences. These
antibodies recognize a 39 kD protein in mouse cell lines. Preliminary evidence suggests that they
stain an intracellular membrane compartment.
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INTRODUCTION
The development of techniques in the earlyl980s that allow the introduction of cloned DNA into
the germline of mice has transformed mammalian molecular genetics (Jaenisch, 1988). It became
a major tool in the analysis of gene expression and function, but also permits to apply methods of
insertional mutagenesis for the discovery of novel mouse genes, in a manner similar to the way
transposable elements were used in the molecular genetic studies of yeast, maize or the fly (for a
review, see Rudnicki and Jaenisch, 1991). The process of generating transgenic mice involves
the integration of foreign DNA into host chromosomal sequences, and thus potentially disrupts or
insertionally mutates endogenous genes at a certain frequency. Indeed most insertional
mutations were initially recovered serendipitously when generating transgenic mice for a different
purpose. The generation of mice carrying foreign DNA for the purpose of studying the expression
and function of the transgenic sequences involves DNA microinjection into the male pronucleus
of a one-cell embryo. A distinct way to efficiently introduce exogenous DNA into the germline of
mice (which however does not, in most cases, leads to expression of the introduced sequences)
is by retroviral infection of preimplantation embryos. Both methods of DNA microinjection and
retroviral infection induce insertional mutations at similar frequencies of -5-10 %. However, they
highly differ in the way the exogenous DNA integrates into host sequences, and therefore in the
resulting structure of the mutation and the clonability of the affected locus. Pronuclear
microinjections lead most of the time to a profound alteration of the integration site, frequently
with tandem arrays of copies of the transgene and complex rearrangements of the flanking
sequences, including deletions, inversions, duplications and translocations. Cloning of the
disrupted locus is in most cases extremely difficult. Retroviral infection instead produces
integration of a single provirus, with only a few bp duplication on either side, and therefore is a
superior method for mutagenesis, allowing efficient cloning of the flanking regions.
More recently, the advent of ES cell technology has contributed a major advance in the
field of insertional mutagenesis, permitting a more rational and directed approach to the
generation of mutants. The availability of cells in culture with a germ line potential allows to apply
screening and selection procedures to enrich for insertional mutations before the production of
an animal. This involves the design of new vectors that function as enhancer traps or promoter
traps allowing to select for the insertions that occurred in the vicinity of, or within a gene. The use
of vectors that express P3-galactosidase only if integrated within a host gene from which they
acquire regulatory control sequences allows to screen for expression patterns of interest upon
introduction of the cells within a host embryo. Although in its simpler form, the ES cell approach
selects for genes that are expressed in ES cells, it has proven to allow identification of genes with
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a variety of expression patterns, including developmentally regulated ones. Improved strategies
are being developed for generation of mutations affecting specific biological processes.
Initial experiments that used the retroviral infection approach employed the wild-type,
replication-competent Moloney-Murine Leukemia Virus (Mo-MLV) (for a review, see Rudnicki and
Jaenisch, 1991). However, replication of the virus often occurs in the animal, leading to viremia
and leukemia. More recently, defective or replication-incompetent recombinant retroviruses can
be produced from packaging cell lines in the absence of formation of wild-type virus. In a total of
66 mouse strains carrying individual proviral integrations, four displayed a mutant phenotype
when bred to homozygosity. The Movl3 strain was the first insertional mutant described. The
phenotype of embryonic lethality at E13 was found to be associated with integration of the Mo-
MLV provirus in the first intron of the al (I) collagen gene. The recombinant retrovirus MPSVneo
produced two other insertional mutants. The Mpvl 7 mouse strain manifested a lethal nephrotic
syndrome in homozygous adults (Weiher et al., 1990), and retroviral integration at the Mpv20
locus resulted in preimplantation lethality (Gray et al.).
Infection of preimplantation embryos with a recombinant replication-competent Mo-MLV,
containing a bacterial supF gene within each LTR to facilitate cloning of the targeted locus (Reik et
al., 1985; Soriano and Jaenisch, 1986), was used to generate 31 transgenic mouse strains
(Movl5 to 45). One of these, Mov34, exhibited a recessive lethal phenotype. Embryos
homozygous for the Mov34 proviral integration develop to blastocysts but die soon after
implantation, before reaching the egg cylinder stage. The chromosomal locus containing the
provirus was cloned and analyzed. Integration occurred in the first intron of a 7-exon gene. Unlike
Movl3, proviral insertion occurred in the same transcriptional orientation as the host gene. The
Mov34 locus gene was found to express an abundant and widely expressed 1.7 kb transcript,
whose sequence is widely conserved among species. The Mov34 locus maps to mouse
chromosome 8, human chromosomal region 16q23-q24, and the Drosophila homologue was
mapped to 60B,C on chromosome 2 (Gridley et al., 1990). The murine and Drosophila proteins
share 62 % amino acid identity, and have no significant homology with proteins of known function.
The murine amino acid sequence predicts a protein of - 35 kD, displaying an unusual highly
hydrophilic C-terminal domain, that consists of alternating positive and negative charged residues
(Gridley et al., 1990).
The timing of lethality of the mutant shortly after implantation may indicate that, in the
mouse, maternal components of the oocyte operate to rescue the homozygous mutant for 5 days
of preimplantation development. Together, the conservation of Mov34 sequences among
species, the wide tissue distribution of the associated transcript, and the mutant early lethality
suggest that, rather than a function specific to implantation events, the Mov34 gene carries a
function general to the biology of the cell or to the biology of tissues.
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RESULTS
Expression of the Mov34 mRNA in oocytes, preimplantation embryos and adult
tissues
Mov34 homozygous mutant embryos die shortly after implantation. It has not been possible to
recover any live conceptuses with a Mov34/Mov34 genotype at any postimplantation stage. In
intercrosses between animals heterozygous for the Mov34 mutation, the frequency of dead or
resorbed embryos is 25% at the egg-cylinder stage (E6.5), indicating that mutant embryos do
undergo implantation, but fail very soon any further developement (Soriano et al., 1987).
Because the Mov34 gene is an abundantly and nearly ubiquitously transcribed gene, it
has been speculated to encode a general function, common to all cells. One hypothesis is that
survival of homozygous mutant embryos during the 5 days preceding implantation is attributable
to maternal rescue by the Mov34 mRNA in the oocyte. To assess this possibility, we have
examined mRNA expression in oocytes and later preimplantation stages. Northern blot analysis
with a riboprobe was performed, as this method was previously shown to allow detection of
specific maternal RNAs in single oocytes (Huarte et al., 1987).
Primary oocytes were isolated manually from the ovary. Care was taken not to include
attached follicular cells, by repeated pipetting and visual inspection. Secondary oocytes were
isolated from the oviducts of superovulated females. A single 1.7 kb transcript was previously
identified at the Mov34 locus (Soriano et al., 1987). Northern analysis of the oocyte samples
revealed that the transcript was abundant as a maternal message in the primary oocyte (Fig.1, lane
1), and that in the course of meiotic maturation, the transcript decreased in size (lane 2), likely due
to deadenylation of transcripts occurring at this time (see Discussion). A profile of expression of
the Mov34 transcript throughout meiosis and preimplantation stages is shown in Fig.2. Primary
oocytes in lane 1 were separated from their zona pellucida, in order to rule out the possibility that
the signal obtained in oocytes is contributed by the follicular cell extensions existing through the
zona. The same signal intensity was obtained as in intact primary oocytes (compare lanes 1 and 2),
confirming that the transcript is associated with the oocyte only. After reduction in size and
amount in secondary oocytes (lane 4), the Mov34 transcript was degraded after fertilization (1-cell
embryos, lanes 5,6). Reappearance of the transcript by embryonic gene expression occurred at
the 4-cell stage (lane 9), followed by accumulation throughout the morula and blastocyst stages
(lanes 10 and 11). Thus the early expression pattern of the Mov34 gene is the one of a
constitutively active gene. Activation of the gene is concomitant with activation of the embryonic
genome.
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We next examined expression of the 1.7 kb Mov34 transcript in adult mouse tissues
(Fig.3), and confirmed its presence in similar amounts in all solid tissues tested (Soriano et al.,
1987). In whole blood, however, the transcript was absent (not shown), as previously found
(Soriano et al., 1987). In mouse cell lines, mRNA expression was found to be ubiquitous as well.
Embryo Carcinoma (F9, before and after differentiation), Embryonic Stem cells, a variety of
hematopoietic cells (EL4, MEL), and fibroblasts (3T3) were found to express the Mov34 gene
highly (not shown).
Raising of antisera to the predicted Mov34 protein sequence
In order to localize the Mov34 gene product within the cell, and begin a functional analysis, we
raised antisera in rabbits. The longest open reading frame found in the full-length Mov34 cDNA
(Gridley et al., 1991) consists of 321 amino acids. Two peptide sequences were chosen in this
predicted amino acid sequence (see the boxed regions in Fig. 4) and synthesized chemically.
Peptide 1 represents the 15-amino acid C-terminal of the protein. This encompasses about one
half of the highly charged region, consisting of alternated positive and negative residues, which is
found at the C-terminal of the Mov34 protein sequence. Peptide 2 is a 12-residue stretch
consisting of amino acids 272 to 283 (Gridley et al, 1991).
Each peptide was coupled to thyroglobulin using SMCC as crosslinker. These peptide-
thyroglobulin conjugates were used to immunize rabbits (2 rabbits per conjugate). We next
synthesized 2 other conjugates using the same peptides, with BSA as carrier instead of
thyroglobulin, and MBS crosslinker instead of SMCC. These conjugates share structurally only
the peptide with the ones used as immunogens, and were used to monitor the peptide-specific
response in the antisera. This analysis was done by Western blotting, where various amounts of
the BSA-peptide conjugates were run on a SDS-PAGE gel. Each rabbit was found to have raised
a strong response, exclusively of the expected specificity (not shown).
To verify that the antisera recognized also the peptides in the context of the whole
protein, we next synthesized in vitro the Mov34 protein. The p28 cDNA was transcribed using
SP6 RNA polymerase, the transcripts were isolated and used as templates in an in vitro translation
reaction catalyzed by rabbit reticulocyte lysates. Whole antisera, or affinity-purified antibodies (see
below), were then used to immunoprecipitate the translation products. Figure 5 shows that both
rabbits immunized with peptide 1-conjugate (animals #1 and #2) produced antibodies that
efficiently immunoprecipitated the Mov34 gene product (lanes 5 and 8). This reaction was
inhibited by an excess of peptide 1 (lanes 6 and 9), but not of peptide 2 (lanes 7 and 10). Rabbits
immunized with peptide 2-conjugate (animals #3 and #4), however, manifested a much weaker
response in this assay. One animal antiserum weakly immunoprecipitated the Mov34 protein (lane
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11, clearly visible upon longer exposure), and the other not detectably. As the antibody response
against the peptide 2-BSA conjugate as assayed by Western analysis was strong in both these
animals (see above), this may indicate that peptide 2 is poorly accessible in the context of the
whole polypeptide structure.
Identification of the Mov34 protein in mouse cells
We next sought to identify the product of the Mov34 gene in mouse cells. #1 antiserum was
titered on cytoplasmic + membrane (C) and nuclear (N) extracts of NIH-3T3 fibroblasts by Western
analysis, and found to recognize in both cellular fractions, and at dilutions from (1:1,000) to
(1:16,000), a protein of approximate 39 kD MW as major antigen (Fig. 6, lanes 4 and 5). The
recognition was specifically abolished by co-incubation with competitor peptide 1 (lanes 6 and 7).
At a dilution of (1:16,000), the 39 kD protein was the only band recognized. #2 antiserum at
(1:16,000) also recognized a 39 kD band as only protein in the cytoplasmic fraction, but in addition
strongly recognized a ~ 65 kD protein in the nuclear fraction (not shown). In this Western assay,
antisera #3 and #4, raised against peptide 2, did not recognize a 39 kD protein (not shown).
Affinity purification of the antisera on columns coupled with the relevant peptides greatly
enriched the titer of antibodies recognizing the 39 kD protein (Fig. 7). In this experiment, whole
antisera #1, #2 and #3 (lanes labelled 'W') faintly recognized the 39 kD protein in cytoplasmic and
nuclear extracts of 3T3 fibroblasts ('3') or EL4 lymphoma cells ('E'). However, the 39 kD protein
was strongly recognized by all three corresponding fractions that were eluted from the affinity
columns (lanes labelled 'A'). In cytoplasmic extracts from fibroblasts, antibodies from antisera #1
and #2 were specific for the 39 kD protein. However in nuclear fractions of fibroblasts and in EL4
cells, one to three additional protein species were also recognized. The relatedness of these
other antigens to the Mov34 gene product is unknown. In summary, antibodies raised against two
different regions of the Mov34 protein both recognized a 39 kD protein antigen that partitions in
cytoplasmic as well as nuclear cellular fractions. In the cytoplasm of fibroblasts, this is the only
protein recognized by the anti C-terminal (peptide 1) antibodies.
Localization of the Mov34 protein in mouse cells
We used these antibodies in immunostaining experiments. 3T3 fibroblasts were allowed to attach
on coverslips, and indirect cell staining was performed using FITC-labeled goat-anti-rabbit
secondary antibodies. All 4 sources of antibodies stained a cytoplasmic, vesicular compartment,
displaying sometimes a reticulate organization (Fig. 8). Using antibodies from #2 antiserum, some
cells displayed in addition a punctuate nuclear pattern, that could be the only pattern present in
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the cell, or that could be (even in an adjacent cell) associated with the punctuate cytoplasmic
pattern (not shown).
This staining pattern, observed both with the anti-C-terminal and the anti-internal peptide
antibodies, suggests that the Mov34 protein is associated with a membrane-bound intracellular
compartment. The specificity of the staining, however, remains to be confirmed by competition
with the cognate peptide. If this specificity is confirmed, the precise localization of the Mov34
antigen in the cell should be determined by performing co-staining in presence of markers of the
various subcellular compartments in conditions of fixation that preserve the ER tubular network
(Munro and Pelham, 1987). Subcellular fractionation experiments should complement these data.
As the secretory apparatus of the cell can be morphologically and functionally manipulated with a
variety of drugs and treatments, these should be used as well, and may provide informative clues
to the function of this protein.
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Figure 1. The Mov34 mRNA is maternally encoded in the oocyte.
Northern blot analysis of (OI) 205 primary oocytes isolated from ovaries,
and (011) 319 secondary oocytes isolated from oviducts of superovulated
females. The probe is a T7 riboprobe transcribed using p28 linearized with
Scal as a template.
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Figure 2. Expression of the Mov34 mRNA during preimplantation development. Northern
ir, .rivsis cf total RNA from (lane 1) 50 zona pellucida-denuded primary oocytes, (lane 2) 50
.)r rn~1rv ocVttes (strain FVB). (lane 3) 50 primary oocytes (strain 129), (lane 4) 50 secondary
,ccVyt; lrne 5) 50 1 -cell embryos,(lane 6) 47 1-cell embryos, (lane 7) 30 2-cell embryos, (lane
S.A. (:to enbryos (larne 9) 27 4-cell embryos, (lane 10) 28 morulae, (lane 11) 29 blastocysts;
' ,,'. .d wt' rp8 r;oprobe as in Fig. 1 This experiment was repeated two other times with
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Figure 3. Expression of the Mov34 mRNA in adult tissues. Northern blotanalysis of RNA from the organs indicated. Each lane contains 10 ug of totalRNA, except 8 (ovaries) which contains half this amount, and 9 (spleen) whichcontains twice this amount.
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-78 GAGGAGCGGCCTGTGTCGCTGCGGTTGCTGGTGTTTGCGGGTTGCAGGGAGCCGGGCCGG
-18 TGGTCGGGCTGTGTCGCGATGCCGGAGCTGGCGGTGCAGAAGGTGGTGGTTCACCCCCTG
MetProGluLeuAlaValGlnLysValValValHisProLeu 14
43 GTGCTGCTCAGTGTGGTGGATCATTTCAACCGAATTGGCAAGGTTGGAAACCAGAAGCGG
ValLeuLeuSerValValAspHisPheAsnArgIleGiyLysValGlyAsnGlnLysArg 34
103 GTAGTTGGTGTGCTTTTGGGATCATGGCAAAAGAAAGTACTTGATGTATCCAACAGTTTT
ValValGlyValLeuLeuGlySerTrpGlnLysLysValLeuAspValSerAsnSerPhe 54
163 GCAGTACCTTTTGATGAAGATGACAAAGATGATTCTGTCTGGTTTTTAGACCATGATTAT
AlaValProPheAspGluAspAspLysAspAspSerValTrpPheLeuAspHisAspTyr 74
223 TTGGAAAACATGTATGGGATGTTCAAGAAGGTCAATGCCAGAGAAAGGATAGTTGGGTGG
LeuGluAsnMetTyrGlyMetPheLysLysValAsnAlaArgGluArgIleValGlyTrp 94
283 TACCACACAGGCCCCAAACTGCACAAGAATGATATCGCCATCAATGAACTCATGAAGAGA
TyrHisThrGlyProLysLeuHisLysAsnAspIleAlalleAsnGluLeuMet LysArg 114
343 TACTGCCCCAACTCAGTATTGGTCATTATCGACGTGAAGCCAAAGGACCTAGGACTTCCC
TyrCysProAsnSerValLeuValIleIleAspValLysProLysAspLeuGlyLeuPro 134
403 ACCGAAGCCTACATCTCAGTGGAGGAAGTTCATGACGATGGGACGCCAACGTCAAAACT
ThrGluAlaTyrIleSerValGluGluValHisAspAspGlyThrProThrSerLysThr 154
463 TTTGAGCATGTGACTAGCGAGATTGGAGCAGAGGAGGCGGAGGAAGTCGGAGTGGAGCAC
PheGluHisValThrSerGluIleGlyAlaGluGluAlaGluGluValGlyValGluHis 174
523 TTACTAAGAGACATCAAGGACACTACAGTGGGGACTCTCTCCCAGCGGATCACAAACCAG
LeuLeuArgAspIleLysAspThrThrValGlyThrLeuSerGlnArgIleThrAsnGln 194
583 GTCCATGGCTTGAAGGGACTGAACTCCAAGCTCCTGGATATCAGGAGCTACCTGGAGAAG
ValHisGlyLeuLysGlyLeuAsnSerLysLeuLeuAspIleArgSerTyrLeuGluLys 214
643 GTAGCCAGCGGCAAGCTGCCCATCAACCACCAGATCATATACCAGCTGCAGGACGTCTTC
ValAlaSerGlyLysLeuProIleAsnHisGlnIleIleTyrGlnLeuGlnAspValPhe 234
703 AACCTGCTGCCGGACGCCAGCCTGCAGGAGTTGTCAAGGCCTTCTACCTGAAGACCAAT
AsnLeuLeuProAspAlaSerLeuGlnGluPheValLysAlaPheTyrLeuLysThrAsn 254
763 GACCA TGGTGGTGGTGTACCTGGCCTCGCTGATC CTCTGTGGTCGCCTTGCATAAC P I2
AspG1 etValValValTyrLeuAlaSerLeuI1 EtS erValaalA1 euHisAsn 274
823 CTCATCAA( ACAAGATTGCCAACCGGGATGCCGAGAAGAAGGAGGGACAGGAAAAGGAG
LeulleAsr rsnLysIleAlaAsnAr AspAlaGluLysLysGluGlyGlnGluLysGlu 294
883 GAGAGCAAGAAGGAGAGAAAAGACGACAAAGAGAAGGAGAAGAGCGACGCAGCGAAGAAA p ..l
GluSerLysLysGluArgLysAspAspLysGluLy GluLysSerAspAlaAlaLysLys 314
943 GAAGAGAAAAAGGAGAAAAATAAATGGTGTAGCTTTTTAATTAGTAAATTAAAATCTT
GluGluLysLysGluLysLys nd 334
1003 ATAACCATAACTCCGTGTGCCACTAGGAGGGTCCTTTGTCACATTCAGTGCTTGTGGACA
1063 AGCGCTCTGCCCTGGTCACCCTTGCTGTGGCATTGTGGAGATGAGTGGACAAAAGGACGG
1123 ATCTCAGCCCTACGATACAGCTTCAGTTGCATGA GGGTGTGGTGGCTCAGGTGTC
1183 CGACTTCATGAGGAGAACAACCTAGCCTTGGGCACTCTTCCTTTTATCCTTGAAAGGGAT
1243 TTTTTTTCCTATCTTACAAGATCCATGGGATCGTAATTTTCATAATTGCTAA
1303 ATGGAATTCATGGATCCCATACAATGCCGCCCAACACTTGAGCTTGGACCCTTGTGAACT
1363 TTTGAGACCACACCACCTTTTGGACCTGTAACTAGCATTCTTAGGGCTTGGGGTCCAAGG
1423 CCATGTATTGTTTACCTTCAAAGATACAATTAAATGGCTTGGTTTTTAAAAAAAAAAAAA
1482
Figure 4. Sequence of the Mov34 cDNA. Shown are the combined nucleotide sequence of
the overlapping cDNA clones and the predicted amino acid sequence (Gridley et al., 1991).The adenylate residue of the predicted translation initiation codon is numbered nucleotide +1.Nucleotide numbering is shown to the left, and predicted amino acid numbering is shown tothe right. The amino acid sequence of the two peptides used to raise antibodies are boxed,pep1 (C-terminal 15 amino acids) and pep2 (an internal 12-amino acid sequence). Wavy lines
indicate the position of the hypothetical 21-residue membrane-spanning region. The centralArginine residue is circled.
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Figure 5. Immunoprecipitation of the Mov34 cDNA product. The p28 cDNA was
linearized with Xbal, and in vitro transcribed. Transcription products were used as templates
in a rabbit reticulocyte lysate, and immunoprecipitated with anti-C terminal (#1 and #2),
or anti-internal peptide (#3 and #4) affinity-purified antibodies, in presence or absence of competitor
peptide 1 or 2. Peptide 1 corresponds to the C-terminal 15 amino acids of the Mov34 open reading
frame, and peptide 2 corresponds to a 12-residue internal sequence. Lane 1, 1 ul Mov34 in vitro translation.
lane 2, 4ul mock in vitro translation. Indicated on the left, Molecular Weight standards ( kD).
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Figure 6. Identification of the 39 kD Mov34 gene product in cell lines.
Western blot analysis of 3T3 fibroblast cytoplasmic and cell membrane fraction (C),
or high salt nuclear extract (N), run in reducing conditions. The immunoblots were
allowed to bind to antiserum #1 at the indicated dilution, in the presence (lanes 6 and 7)
or absence of competitor peptide. Lane 3 contains BSA conjugated with peptide 1 (50 ng),
as a positive control. On the right, approximate Molecular Weights (kD).
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Figure 8. Indirect immunofluorescence of NIH-3T3 fibroblasts using affinity-purified anti -Mov34
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DISCUSSION
The Mov34 retroviral insertion is one of few mutations in the mouse known to arrest development
after uterine implantation but prior to formation of the egg cylinder, and thus before the onset of
gastrulation. Recently, targeted disruption of the even-skipped gene evxl was shown to cause
early postimplantation lethality of the mouse conceptus (Spyropoulos and Capecchi, 1994). The
evxl mutant phenotype manifests itself the earliest when compared to the other previously
described, periimplantation, pregastrula mutants (Spyropoulos and Capecchi, 1994; and
references therein). This mutant fails to differentiate extraembryonic tissues or to form a yolk sac
cavity. evxl encodes a homeobox transcription factor that has been implicated in the response to
growth factors through the TRE/AP-1 promoter element. The inadequate function of critical
growth factors may provide an explanation for the mutant phenotype (Spyropoulos and
Capecchi, 1994). Other mutants are known to form abnormal egg cylinders, with varying degrees
of tissue disorganization (t0 , fugl, tw73, lethal yellow (AY), velvet coat (Ve), blind (Bld), and c6H).
Among these mutants, only fugl and lethal yellow were molecularly characterized and both
shown to disrupt expression of a protein involved in RNA binding or metabolism (Michaud et al.,
1993; DeGregori et al., 1994).
The Mov34 mutant is similar to the evxl mutant in terms of timing, but the morphological
basis of the lethality has not been fully described. Molecular characterization of the proviral
integration site led to the identification of a 7-exon gene, in the first intron of which the
recombinant Moloney-Leukemia Virus had integrated, apparently causing the lack of expression
of the wild-type 1.7 kb transcript (Gridley et al., 1991). This transcript was found to encode a novel
protein of predicted MW -35 kD and to be widely expressed in adult mouse tissues (Soriano et al.,
1987; Gridley et al., 1991).
In this study, we have analyzed the onset of expression of the Mov34 gene in wild-type
early embryos. We have shown that the 1.7 kb transcript is present as a maternal message in the
primary oocyte. Resumption of meiosis preceding ovulation leads to a shortening of the Mov34
transcript, as is observed for actin messenger RNA (Bachvarova et al., 1985). Shortening of the
actin mRNA during meiotic maturation was shown to be the result of a deadenylation process that
affects some mRNAs, while others are subject to further polyadenylation instead (Huarte et al.,
1987). Similar to actin mRNA, the Mov34 transcript was found to be degraded after fertilization.
During preimplantation development, we first detected the Mov34 transcript at the 4-cell stage,
and observed its accumulation at the morula and blastocyst stages, preceding the appearance of
the mutant phenotype in Mov34/Mov34 embryos. Thus the early expression pattern of the 1.7 kb
transcript is consistent with its deficiency causing the lethality in mutant embryos, and follows the
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pattern of a constitutively expressed mRNA. We have raised antibodies directed against two
distinct peptide sequences in the open reading frame of the cDNA corresponding to the 1.7 kb
transcript, and found that both of them recognized a 39 kD protein antigen in mouse cell lines,
consistent with the size of the Mov34 gene product. Immunostaining of fibroblast cells using
these antibodies revealed a punctuate/reticulate pattern, resembling an intracellular membrane
compartment, such as the endoplasmic reticulum (ER). The observation that the 39 kD protein
recognized in Western blots by the antibodies partitioned both in the cytoplasmic and nuclear
fractions was consistent with an ER localization. These data, although very preliminary, therefore
suggested that the Mov34 gene product is an ER resident protein. Signals that confer ER
localization to a protein have been known for both soluble and transmembrane proteins. A variety
of soluble proteins that reside in the lumen of the ER contain the extreme C-terminal sequence
KDEL, and this sequence was shown to constitute a signal sufficient to retain a reporter soluble
protein in the ER (Munro and Pelham, 1987). Retention signals for transmembrane proteins have
also been studied, and found to consist of less stringently defined short cytoplasmic sequences
that occupy also the extreme C-terminal position in the protein, and that were present in proteins
possessing a putative transmembrane domain (Nilsson et al., 1989; Jackson et al., 1990; Shin et
al., 1991). Mutational analysis demonstrated that two lysines positioned three and four or five
residues from the C-terminal, and a variety of related motifs, conferred ER retention to
transmembrane proteins (Jackson et al., 1990). The Mov34 protein N-terminal displays a
hydrophobic character and potentially acts as a signal peptide. In addition, the protein contains a
-21 amino acid stretch at positions 257 to 277 that displays a high hydrophobicity score
(Eisenberg, 1984), with the exception that it contains an arginine residue exactly in its middle, at
position 267. This region may potentially assume a transmembrane configuration. It is closely
followed in sequence by the extremely hydrophilic C-terminal -36 amino acid domain, which
displays a characteristic alternation of positively and negatively charged residues, with 30 out of
36 residues being charged. This domain does not contain a KDEL sequence. In contrast,
comparison between the motifs that confer ER retention to transmembrane proteins and the C-
terminal of the Mov34 gene product shows close similarities, although the exact sequence
present in the Mov34 gene product was not tested. The presence of these sequence motifs,
together with the cell staining data, led us to hypothesize the following topology for this novel
protein. The N-terminal and the bulk of the polypeptide (256 out of 321 amino acids) would be
located within the ER lumen, the polypeptide would traverse the ER membrane, and the C-
terminal tail would face the cytoplasmic compartment. Although no functional domain has been
identified in the protein, such a topology would predict an intra-luminal function.
Future studies of the Mov34 gene function and of the causes that underly the mutant
phenotype should include a confirmation of the protein intracellular localization, in particular by
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cell fractionation and co-staining of cells with markers of specific cellular compartments.
Morphological analysis, using both light and electron microscopy, of the mutant embryos
surrounding the time of lethality, appears essential for an understanding of the basis of the
developmental arrest. A complementary approach to elucidate the function of the Mov34 gene
will be to derive Embryonic Stem cells from blastocysts produced by heterozygote intercross. This
would allow a determination of whether the Mov34 mutation is a cell-lethal, and if not, what
competence Mov34 deficient cells have for participating in normal development upon
reintroduction into a host embryo. The present genetic background of the Mov34 mutation (a
BALB/c derivative) may however not be permissive for the generation of ES cells. Backcrossing
animals carrying the mutation to C57BL/6, for example, may thus be necessary.
The prospect of the Mov34 protein being a novel ER resident membrane protein, if
confirmed, is exciting. In view of the wide expression of the Mov34 associated transcript in
embryonic and adult tissues, and of the early lethal phenotype, it can be envisaged that the
protein carries out an essential function in the cell secretory machinery, such as transport within
the lumen, protein modification or targeting.
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METHODS
Mouse oocyte and preimplantation embryo collection
Fully-grown primary oocytes were isolated manually from ovaries, and secondary oocytes were
isolated from the oviducts of superovulated females, as described by Huarte et al. (1985).
RNA extraction from oocytes and preimplantation embryos
RNA from a small number of oocytes or embryos was prepared as described in Huarte et al.
(1987). The riboprobe used in Northern blot analysis was synthesized using T7 RNA polymerase
(Promega) on a template of p28 (Gridley et al., 1990), linearized with Scal.
Raising of antisera
Two sequences of the predicted Mov34 protein (Gridley et al., 1990) were chosen and
synthesized with an Applied Systems solid-phase peptide synthesizer. 'pepl' is the C-terminal 15
amino acid peptide: EKSDAAKKEEKKEKK. 'pep2' is an internal 12 amino acid peptide:
LHNLINNKIANR (see Fig.4).
Each peptide was coupled to Thyroglobulin using SMCC cross-linker (from Pierce, see
below), and Thyroglobulin conjugates were used as immunogens in New Zealand white rabbits (2
rabbits per immunogen). The primary immunization was a subcutaneous injection of 1 mg
Thyroglobulin conjugate in complete Freund's adjuvent. Subsequent boosts were with 0.5 mg
conjugate in incomplete Freund's adjuvent, and rabbits were bled 10-15 days after immunization.
To verify the reactivity of the antisera, each peptide was coupled to Bovine Serum
Albumin (BSA) using MBS cross-linker (Pierce), and a titration of BSA conjugates were run on
SDS-PAGE gels, transferred to nitrocellulose, and tested for reactivity with each antiserum. All 4
rabbits were found to have mounted an antibody response with the expected specificity.
Peptide-carrier coupling
10 mg of carrier protein (Thyroglobulin, BSA or Keyhole Limpet Hemocyanin (KLH)) was dissolved
in 0.75 ml of PBS and stirred on a magnetic platform. 1.7 mg of cross-linker (SMCC or MBS),
dissolved in 200 ul dimethylformamide, was added dropwise to the carrier protein, and the
reaction allowed to proceed for 30' at r.t., with continued stirring. After addition of 1.55 ml of 0.1 M
Sodium Phosphate pH 6, the unreacted cross-linker was removed on a Sephadex G-25 gel
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filtration column (PD-10, Pharmacia) equilibrated in 0.1 M Sodium Phosphate pH 6.0. Peptide (5
mg) was then added to the purified reacted carrier, and allowed to couple overnight at r.t. with
stirring. The conjugates were dialyzed against 0.1 M Hepes pH 7.4 at 4 C, and the absorbancy at
280 nm was measured.
Immunoaffinity purification of antibodies
To prepare the peptide antigen column, slurry of Affigel-10 (or -15, BioRad) was transferred to a
glass fritted funnel and washed with 20 volumes of ice-cold deionized water. The moist gel cake
(to create a -2-mi bed volume) was transferred to a test tube, and peptide-carrier conjugate
diluted in 5 ml of 0.1 M Hepes pH 7.4 (see section Peptide carrier coupling) was immediately
added. The gel slurry was gently agitated on a rocker for 2 hrs at 4 C. To block the remaining active
esters at the end of the reaction, 0.1 ml of 1 M ethanolamine-HCI (pH 8) was added and allowed to
react for 1 hr at 4 C with agitation. The gel slurry was then poured into a column (BioRad
Econocolumn). The supernatant draining off the column was collected and the coupling
efficiency checked (see Harlow and Lane, 1988). The gel was washed with 0.1 M Hepes pH 7.4,
until the OD280 of the eluent was zero. The gel was then submitted to a wash with 0.58% acetic
acid (used later to elute specific antibodies), followed by a wash with PBS to restore the pH. A
basic wash with 0.1 M triethylamine (pH 11.5) (also used to elute specific antibodies), followed by
neutralization with PBS, was next performed. The column was then ready to use, or otherwise
stored at 4 C, in PBS with 0.02% NaN3.
To affinity purify antibodies from serum, 4 ml of antiserum were added to 4 ml of PBS, and
added to the antigen-coupled gel. The mixture was agitated by rotating overnight at 4 C. The
column was then washed with PBS (20 bed volumes) until the effluent read zero at 280 nm. A
high salt wash with 5 ml of PBS / 2 M NaCI was performed, followed by a wash with 20 bed volumes
of 10 mM Sodium Phosphate pH 6.8. Antibodies bound by acid-sensitive interactions were eluted
from the column by passing 10 bed volumes of 0.58% acetic acid through the column, collecting
1 ml fractions (in tubes containing 110 ul 1 M Tris base, for quick neutralization of the antibodies),
and monitoring absorbancy at 280 nm. Optionally, after a 10 mM Sodium Phosphate pH 8 wash, a
basic elution step was carried out by passing 10 bed volumes of 0.1 M triethylamine (pH 11.5)
through the column, and collecting 1 ml fractions in tubes that contained 110 ul 1M monobasic
Sodium Phosphate. The column was restored to neutral pH with a PBS wash, and stored at 4 C for
later use. The fractions which absorbed at 280 nm were pooled and dialyzed overnight against
PBS, 0.02% NaN3. Antibodies were stored frozen in small aliquots.
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In vitro translation and immunoprecipitation of the Mov34 gene product
The p28 plasmid was linearized with BamHI and used as template in a transcription reaction by
SP6 RNA polymerase (Promega) in presence of m7G(5')ppp(5')G cap (Pharmacia). The RNA was
translated in rabbit reticulocyte lysate (Promega). Methods were as suggested by the
manufacturer.
The in vitro translation reaction (50 ul) was made to 1.2 ml volume with NET-BSA buffer
(50 mM Tris-HCI pH 7.5, 150 mM NaCI, 0.1% NP-40, 1 mM EDTA, 2.5 mg/mi BSA, 0.02% Na N3),
and precleared by addition of 36 ul preimmune serum, incubation for an hr on ice, and adsorbtion
on Protein A Sepharose (400 ul) for an hr at 4 C. After centrifugation in a microfuge for 30", the
supernatant was split in 12 tubes, which were made to 500 ul each with NET-BSA. Each tube was
incubated overnight on ice with 5 ul antiserum or 2 ug of affinity-purified antibodies, in the
presence or absence of BSA-peptide conjugate (15 ug) as competitor. Protein A Sepharose (100
ul) was added, adsorbtion allowed for an hr at 4 C with agitation, and the tubes were centrifuged
for 30". The beads were washed 2 X with NET-BSA buffer, 1 X with NET-BSA-0.5 M NaCI, and 1 X
with 10 mM Tris-HCI (pH 7.5), 0.1% NP-40. Immune complexes were dissociated by addition of 40
ul of 2 X Laemmli sample buffer in presence of 0.1 M DTT. The tubes were heated at 90 C for 10',
and loaded on a 10% acrylamide SDS-PAGE gel. The gel was fixed and fluorography was
performed using Amplify (Amersham).
Cell protein extracts
Cells were harvested and the pellet washed 3 times in cold PBS and resuspended in 5-10
volumes of lysis buffer A (0.3 M sucrose, 20 mM Tris-HCI pH 8.0, 20 mM Hepes pH 7.3, 50 mM
NaCI, 0.4% NP-40, 1 mM EDTA pH 8.0, 1 mM EGTA pH 8.0) in the presence of 2 mM PMSF and 1
U/ml aprotinin. The lysed cells were immediately centrifuged for 5' at 1,500 rpm, and resulting
supernatant was saved as the cytoplasm and membrane fraction (C). The pellet was washed once
in buffer A, and resuspended in 5 volumes of lysis buffer B (25% glycerol, 20 mM Tris-HCI pH 8.0,
20 mM Hepes pH 7.3, 530 mM NaCl, 0.1% NP-40, 0.1 mM EDTA pH 8.0, 0.1 mM EGTA pH 8.0) in
presence of protease inhibitors as above. Nuclei were then incubated on ice for 20' and spun for
5' at 1,500 rpm. The supernatant was used as nuclear extract (N). Protein quantitation was
performed using the BCA assay (Pierce).
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Western analysis
Western analysis was as described in Vassalli et al. (1994). In some experiments (Fig.6), the
alkaline phosphatase method (Lane and Harlow, 1988) was used for detection, instead of
Enhanced Chemiluminescence (Amersham).
Immunofluorescence
NIH-3T3 fibroblasts were trypsinized, resuspended at 30,000 cells/ml, seeded onto sterile glass
coverslips in 24-well dishes, and allowed to attach overnight. After 2 washes in Hepes-Buffered
Saline (HBS) (37 C), cells were fixed in Methanol : Acetone (1:1) for 5'. Organic solvents were
prechilled at -20 C and mixed just before use. Coverslips were allowed to air dry for 5', and washed
3 X 10' in PBS on a rotating platform. All subsequent washes were performed at r.t. with agitation
on a rotating platform. Preincubation of the fixed cells was done in PBS / 1% BSA / 3% Normal
Goat Serum for 1 hr at r.t. The primary antibodies were diluted in PBS / 1% BSA, with or without
competitor peptide (as peptide-BSA conjugate), incubated on ice for an hour, spun in microfuge
for 10' at 4 C, and applied onto the fixed cells in a volume of 100 ul or more. Binding was allowed
overnight at r.t. Cells were washed 1 X 10' in PBS / 1% BSA, and 2 X 10' in PBS alone. Fixed cells
were then preincubated as before, and incubated for 45' at r.t. in FITC or RITC conjugated Goat-
Anti-Rabbit secondary antibodies that had been freshly diluted (1:100) in PBS / 1% BSA / 3%
normal goat serum. Fixed cells were washed 3 X 10' in PBS, before mounting.
Immunofluorescence alternate protocol
Cells were seeded at 30,000 cells / ml / well onto sterilized glass coverslips in 24-well plates, and
allowed to attach overnight. After 2 washes with HBS or PBS (37 C), cells were fixed with 3%
paraformaldehyde in PBS for 10' at 25 C, washed 3 X 5' with PBS on a rotating platform, and
permeabilized with PBS / 0.1% BSA with saponin at 0.15%, and rinsed 2 X 5' in PBS. After a
preincubation step for an hr in PBS / 1% BSA / 0.01% saponin, the fixed cells were incubated
overnight at 4 C in primary antibodies diluted in the same buffer. Cells were washed 3 X 10' in PBS
/ 0.01% saponin, preincubated as before, and incubated in secondary antibodies diluted (1:100)
in PBS / 1% BSA / 0.01% saponin for 45' at r.t. Three washes of 10' each in PBS / 0.01% saponin
were done, and the coverslips mounted.
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